{"text": "These studies showed an added antihypertensive response at trough ( 24 hours post - dosing ) of hydrochlorothiazide 12.5 or 25 mg added to losartan 50 mg of 5.5/3.5 and 10.0/6.0 mmHg , respectively .", "label": "", "metadata": {}, "score": "21.575226"}
{"text": "The degree to which hydrochlorothiazide is removed by hemodialysis has not been established .Dosing must be individualized .Losartan can be administered once or twice daily at total daily doses of 25 to 100 mg .", "label": "", "metadata": {}, "score": "27.977377"}
{"text": "There was no evidence of teratogenicity in rats or rabbits treated with a maximum losartan potassium dose of 10 mg / kg / day in combination with 2.5 mg / kg / day of hydrochlorothiazide .", "label": "", "metadata": {}, "score": "28.652168"}
{"text": "These dosages have been shown to provide respective systemic exposures ( AUCs ) for losartan , its active metabolite and hydrochlorothiazide that are approximately 60 , 60 and 30 times greater than those achieved in humans with 100 mg of losartan potassium in combination with 25 mg of hydrochlorothiazide .", "label": "", "metadata": {}, "score": "28.997353"}
{"text": "Minimal conversion of losartan to the active metabolite ( less than 1 % of the dose compared to 14 % of the dose in normal subjects ) was seen in about one percent of individuals studied .", "label": "", "metadata": {}, "score": "29.53145"}
{"text": "Three additional studies examined the antihypertensive effects of losartan and hydrochlorothiazide in combination .The 4 studies of losartan monotherapy included a total of 1075 patients randomized to several doses of losartan and 334 to placebo .", "label": "", "metadata": {}, "score": "29.926182"}
{"text": "Losartan Potassium .Significant lethality was observed in mice and rats after oral administration of 1000 mg / kg and 2000 mg / kg , respectively , about 44 and 170 times the maximum recommended human dose on a mg / m 2 basis .", "label": "", "metadata": {}, "score": "30.124615"}
{"text": "Losartan Potassium - Hydrochlorothiazide .The 3 controlled studies of losartan and hydrochlorothiazide included over 1300 patients assessing the antihypertensive efficacy of various doses of losartan ( 25 , 50 and 100 mg ) and concomitant hydrochlorothiazide ( 6.25 , 12.5 and 25 mg ) .", "label": "", "metadata": {}, "score": "30.471048"}
{"text": "In this study , renal clearance was reduced by 55 - 85 % for both losartan and its active metabolite in patients with mild or moderate renal insufficiency .", "label": "", "metadata": {}, "score": "30.675209"}
{"text": "The antihypertensive effects of losartan were demonstrated principally in 4 placebo - controlled , 6- to 12-week trials of dosages from 10 to 150 mg per day in patients with baseline diastolic blood pressures of 95 - 115 .", "label": "", "metadata": {}, "score": "31.23796"}
{"text": "SPL Patient Package Insert .Patient Information HYZAAR \u00ae ( \" HY - zar \" ) ( losartan potassium - hydrochlorothiazide tablets ) 50 - 12.5 mg , 100 - 12.5 mg , 100 - 25 mg Rx only .", "label": "", "metadata": {}, "score": "31.868898"}
{"text": "ADVERSE REACTIONS .Losartan potassium - hydrochlorothiazide has been evaluated for safety in 858 patients treated for essential hypertension and 3889 patients treated for hypertension and left ventricular hypertrophy .", "label": "", "metadata": {}, "score": "32.127254"}
{"text": "Its use in such patients as a means of losartan titration is , therefore , not recommended ( see DOSAGE AND ADMINISTRATION ) .Drug Interactions .", "label": "", "metadata": {}, "score": "32.691036"}
{"text": "Compared to normal subjects , the total plasma clearance of losartan in patients with hepatic insufficiency was about 50 % lower , and the oral bioavailability was about 2 times higher .", "label": "", "metadata": {}, "score": "33.442123"}
{"text": "Necessary treatment was provided .Table 1 : Demographic characteristics of the volunteers administered with 30 mg gliclazide MR tablets .Pharmacokinetics and Bioequivalence under Fasted Condition .", "label": "", "metadata": {}, "score": "33.829803"}
{"text": "Respective AUCs for losartan , its active metabolite and hydrochlorothiazide at these dosages in rats were approximately 35 , 10 and 10 times greater than those achieved in humans with the administration of 100 mg of losartan in combination with 25 mg hydrochlorothiazide .", "label": "", "metadata": {}, "score": "34.00885"}
{"text": "Plasma concentrations of losartan were about twice as high in female hypertensives as male hypertensives , but concentrations of the active metabolite were similar in males and females .", "label": "", "metadata": {}, "score": "34.030457"}
{"text": "Losartan Potassium .Hypertension .Losartan inhibits the pressor effect of angiotensin II ( as well as angiotensin I ) infusions .A dose of 100 mg inhibits the pressor effect by about 85 % at peak with 25 - 40 % inhibition persisting for 24 hours .", "label": "", "metadata": {}, "score": "34.364674"}
{"text": "Brief Summary .This study has two parts .In the second part , the safety and tolerability of long - term use of open - label losartan / HCTZ / amlodipine in participants with hypertension will be evaluated .", "label": "", "metadata": {}, "score": "34.9372"}
{"text": "The mean length of follow - up was 4.8 years .At the end of study or at the last visit before a primary endpoint , 77 % of the group treated with losartan and 73 % of the group treated with atenolol were still taking study medication .", "label": "", "metadata": {}, "score": "35.249653"}
{"text": "The overall response to the combination was similar for Black and non - Black patients .Patients were randomized to either losartan and hydrochlorothiazide ( 50 - 12.5 mg , once daily ) or to losartan ( 50 mg , once daily ) and followed for blood pressure response .", "label": "", "metadata": {}, "score": "35.63547"}
{"text": "One tablet containing 50 mg losartan potassium and 12.5 mg hydrochlorothiazide , orally , once daily , for 8 weeks .Drug : Placebo to MK-0954E .", "label": "", "metadata": {}, "score": "35.77412"}
{"text": "A Bioequivalence Study of Test and Reference Fosinopril Sodium/ Hydrochlorothiazide 20/12.5 mg Tablets Under Fasting Conditions .Brief Summary .The objective of this study was to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20 - 12.5 mg tablets by Ranbaxy Laboratories Limited with that of Monopril \u00ae .", "label": "", "metadata": {}, "score": "35.790024"}
{"text": "HYZAAR \u00ae 100 - 12.5 ( LOSARTAN POTASSIUM - HYDROCHLOROTHIAZIDE TABLETS )HYZAAR \u00ae 100 - 25 ( LOSARTAN POTASSIUM - HYDROCHLOROTHIAZIDE TABLETS ) .When used in pregnancy during the second and third trimesters , drugs that act directly on the renin - angiotensin system can cause injury and even death to the developing fetus .", "label": "", "metadata": {}, "score": "36.2644"}
{"text": "This formulation gains more interest as it gives better diabetic control and improves patient compliance [ 6 , 7 ] .Modified release dosage forms of gliclazide are generally tailored in a hydrophilic matrix base which expands once in contact with gastrointestinal fluid to form a gel layer which gradually deliberates the drug over 24 h [ 8 ] .", "label": "", "metadata": {}, "score": "36.2825"}
{"text": "The pharmacokinetics of losartan and its active metabolite are linear with oral losartan doses up to 200 mg and do not change over time .Neither losartan nor its metabolite accumulate in plasma upon repeated once - daily dosing .", "label": "", "metadata": {}, "score": "36.453407"}
{"text": "Similarly , a study conducted by Maciejewski and Hilleman compared the effectiveness of the same microcoated 160 mg tablet formulation with the same 145 mg nanoparticle tablet formulation in patients with CHD and dyslipidemia [ 44 ] .", "label": "", "metadata": {}, "score": "37.249523"}
{"text": "Bioequivalence of two products of modified - release gliclazide tablets was studied at the single dose of 30 mg .Both products were well tolerated after oral administration , and food had no influence on their bioavailability .", "label": "", "metadata": {}, "score": "37.510857"}
{"text": "Coadministration of losartan and cimetidine led to an increase of about 18 % in AUC of losartan but did not affect the pharmacokinetics of its active metabolite .", "label": "", "metadata": {}, "score": "37.605793"}
{"text": "LC - MS - MS was found to improve the quantitation of pitavastatin in plasma and was successfully applied in pharmacokinetic studies .Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions .", "label": "", "metadata": {}, "score": "37.65535"}
{"text": "Losartan , administered for 12 days , did not affect the pharmacokinetics or pharmacodynamics of a single dose of warfarin .Losartan did not affect the pharmacokinetics of oral or intravenous digoxin .", "label": "", "metadata": {}, "score": "37.748367"}
{"text": "In addition to the active carboxylic acid metabolite , several inactive metabolites are formed .Following oral and intravenous administration of 14 C - labeled losartan potassium , circulating plasma radioactivity is primarily attributed to losartan and its active metabolite .", "label": "", "metadata": {}, "score": "37.768185"}
{"text": "The assay of 6 individual tablets passed the USP limit of 90 to 110 % of drug ( Table S4 in Supplementary Material ) with a relative standard deviation of 0.023 .", "label": "", "metadata": {}, "score": "37.775845"}
{"text": "About 14 % of an orally - administered dose of losartan is converted to the active metabolite .Mean peak concentrations of losartan and its active metabolite are reached in 1 hour and in 3 - 4 hours , respectively .", "label": "", "metadata": {}, "score": "37.814762"}
{"text": "Patients were randomized to receive once daily losartan 50 mg or atenolol 50 mg .In efforts to control blood pressure , the patients in both arms of the LIFE study were coadministered hydrochlorothiazide the majority of time they were on study drug ( 73.9 % and 72.4 % of days in the losartan and atenolol arms , respectively ) .", "label": "", "metadata": {}, "score": "37.81896"}
{"text": "The formulation developed with these agents was safe to use as there were no serious adverse events developed during the conduction of the clinical trial on the healthy subjects .", "label": "", "metadata": {}, "score": "38.17582"}
{"text": "Plasma protein binding is constant over the concentration range achieved with recommended doses .Studies in rats indicate that losartan crosses the blood - brain barrier poorly , if at all .", "label": "", "metadata": {}, "score": "38.50907"}
{"text": "Drug : Placebo to losartan potassium ( + ) hydrochlorothiazide .One tablet containing placebo , orally , once daily , for 8 weeks .Interventions : .", "label": "", "metadata": {}, "score": "38.62994"}
{"text": "Hypertension .Intervention ICMJE .Drug : losartan potassium ( + ) hydrochlorothiazide ( + ) amlodipine besylate ( MK-0954E ) .One tablet containing 50 mg losartan potassium , 12.5 mg hydrochlorothiazide , and 5 mg amlodipine besylate , orally , once daily , for up to 52 weeks .", "label": "", "metadata": {}, "score": "38.82267"}
{"text": "Losartan Potassium .No significant drug - drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .", "label": "", "metadata": {}, "score": "38.823696"}
{"text": "Detailed Description .This study was a single dose , randomized , two period , two treatment , two sequence crossover study design was used to evaluate the relative bioavailability of Fosinopril sodium and hydrochlorothiazide tablet products when dose ( 1 x 20 - 12.5 mg ) under fasting conditions .", "label": "", "metadata": {}, "score": "39.307648"}
{"text": "Oxidation of the 5-hydroxymethyl group on the imidazole ring results in the active metabolite of losartan .Hydrochlorothiazide is 6-chloro-3,4-dihydro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide .", "label": "", "metadata": {}, "score": "39.449852"}
{"text": "Losartan Potassium .Losartan potassium was not carcinogenic when administered at maximally tolerated dosages to rats and mice for 105 and 92 weeks , respectively .", "label": "", "metadata": {}, "score": "39.691467"}
{"text": "Both losartan and its principal active metabolite do not exhibit any partial agonist activity at the AT 1 receptor and have much greater affinity ( about 1000-fold ) for the AT 1 receptor than for the AT 2 receptor .", "label": "", "metadata": {}, "score": "39.736275"}
{"text": "A patient whose blood pressure is not adequately controlled with losartan 100 mg monotherapy ( see above ) may be switched to HYZAAR 100 - 12.5 once daily .", "label": "", "metadata": {}, "score": "39.785046"}
{"text": "The combination of losartan / hydrochlorothiazide 50/12.5 mg resulted in an approximately additive placebo - adjusted systolic / diastolic response ( 15.5/9.0 mmHg for the combination compared to 8.5/5.0 mmHg for losartan alone and 7.0/3.0 mmHg for hydrochlorothiazide alone ) .", "label": "", "metadata": {}, "score": "39.880207"}
{"text": "However , the LIFE study does not provide evidence that the benefits of losartan on reducing the risk of cardiovascular events in hypertensive patients with left ventricular hypertrophy apply to Black patients .", "label": "", "metadata": {}, "score": "40.248005"}
{"text": "Many research groups have reported bioavailability of gliclazide MR based on pharmacokinetic studies in healthy volunteers and diabetes patients [ 7 - 9 ] ; nevertheless , there are scanty reports addressing bioequivalence study of this formulation .", "label": "", "metadata": {}, "score": "40.4942"}
{"text": "General .Losartan Potassium - Hydrochlorothiazide .No patient discontinued due to increases or decreases in serum potassium .The mean decrease in serum potassium in patients treated with various doses of losartan and hydrochlorothiazide was 0.123 mEq / L. In patients treated with various doses of losartan and hydrochlorothiazide , there was also a dose - related decrease in the hypokalemic response to hydrochlorothiazide as the dose of losartan was increased , as well as a dose - related decrease in serum uric acid with increasing doses of losartan .", "label": "", "metadata": {}, "score": "40.62711"}
{"text": "See WARNINGS , Fetal / Neonatal Morbidity and Mortality .HYZAAR 1 50 - 12.5 ( losartan potassium - hydrochlorothiazide ) , HYZAAR 1 100 - 12.5 ( losartan potassium - hydrochlorothiazide ) and HYZAAR 1 100 - 25 ( losartan potassium - hydrochlorothiazide ) , combine an angiotensin II receptor ( type AT 1 ) antagonist and a diuretic , hydrochlorothiazide .", "label": "", "metadata": {}, "score": "40.69928"}
{"text": "HYZAAR 50 - 12.5 contains 50 mg of losartan potassium and 12.5 mg of hydrochlorothiazide .HYZAAR 100 - 12.5 contains 100 mg of losartan potassium and 12.5 mg of hydrochlorothiazide .", "label": "", "metadata": {}, "score": "40.868088"}
{"text": "Healthy .Intervention ICMJE .Drug : Fosinopril sodium and hydrochlorothiazide 20 - 12.5 mg tablets .Study Arm ( s ) .Experimental : 1 .", "label": "", "metadata": {}, "score": "41.164127"}
{"text": "No adverse events were reported during the study .Based on the 90 % CIs of anti - Xa and anti - IIa activities , heparin clotting assay results , and aPTT in these healthy Chinese male subjects , the test and reference formulations of enoxaparin 60 mg SC met the regulatory requirements for bio - equivalence .", "label": "", "metadata": {}, "score": "41.219864"}
{"text": "Losartan was effective in reducing blood pressure regardless of race , although the effect was somewhat less in Black patients ( usually a low - renin population ) .", "label": "", "metadata": {}, "score": "41.37143"}
{"text": "A Phase III , Randomized , Active - Comparator Controlled Clinical Trial to Study the Efficacy and Safety of MK-0954E in Japanese Patients With Essential Hypertension Uncontrolled With MK-954H", "label": "", "metadata": {}, "score": "41.38398"}
{"text": "Later , tablets combining the classic micronization process with a microcoating network of hydrophilic polyvinylpyrrolidone led to increased dissolution rates and greater bioavailability [ 20 ] .", "label": "", "metadata": {}, "score": "41.386612"}
{"text": "The active metabolite is 10 to 40 times more potent by weight than losartan and appears to be a reversible , non - competitive inhibitor of the AT 1 receptor .", "label": "", "metadata": {}, "score": "41.531662"}
{"text": "Patients on monotherapy were titrated from losartan 50 mg to losartan 100 mg to losartan 150 mg , as needed .The mean blood pressure at baseline for the total population was 171/113 mmHg .", "label": "", "metadata": {}, "score": "41.81368"}
{"text": "For patients who do not respond adequately to HYZAAR 50 - 12.5 after 2 to 4 weeks of therapy , the dosage may be increased to one tablet of HYZAAR 100 - 25 once daily .", "label": "", "metadata": {}, "score": "42.07875"}
{"text": "Armenti JBV .Handbook of Drug - Nutrient Interactions .2nd ed ed .New York , NY : Human Press , 2010 .Sonet B , Vanderbist F , Streel B , Houin G. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers .", "label": "", "metadata": {}, "score": "42.307186"}
{"text": "There was essentially no change in average heart rate in losartan - treated patients in controlled trials .Reduction in the Risk of Stroke .The Losartan Intervention For Endpoint reduction in hypertension ( LIFE ) study was a multinational , double - blind study comparing losartan and atenolol in 9193 hypertensive patients with ECG - documented left ventricular hypertrophy .", "label": "", "metadata": {}, "score": "42.493324"}
{"text": "Replacement Therapy : The combination may be substituted for the titrated components .Dose Titration by Clinical Effect : A patient whose blood pressure is not adequately controlled with losartan monotherapy ( see above ) or hydrochlorothiazide alone , may be switched to HYZAAR 50 - 12.5 ( losartan 50 mg / hydrochlorothiazide 12.5 mg ) once daily .", "label": "", "metadata": {}, "score": "42.558342"}
{"text": "Special Populations .Geriatric and Gender : Losartan pharmacokinetics have been investigated in the elderly ( 65 - 75 years ) and in both genders .", "label": "", "metadata": {}, "score": "42.56991"}
{"text": "For further blood pressure reduction other antihypertensives should be added ( see CLINICAL PHARMACOLOGY , Pharmacodynamics and Clinical Effects , Losartan Potassium , Reduction in the Risk of Stroke ) .", "label": "", "metadata": {}, "score": "42.577526"}
{"text": "Hydrochlorothiazide is effective in doses of 12.5 to 50 mg once daily and can be given at doses of 12.5 to 25 mg as HYZAAR .", "label": "", "metadata": {}, "score": "42.700386"}
{"text": "Losartan and its principal active metabolite block the vasoconstrictor and aldosterone - secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT 1 receptor found in many tissues , ( e.g. , vascular smooth muscle , adrenal gland ) .", "label": "", "metadata": {}, "score": "42.719173"}
{"text": "obtained under the fasted and fed conditions for the test product and reference product .Considering the acceptance criteria of 0.80 - 1.25 , all 90 % CI values were within the criteria which indicates the insignificance of the food effect on the administration of gliclazide MR tablets from both products .", "label": "", "metadata": {}, "score": "42.814133"}
{"text": "doi .Davidson MH , Jones PH .Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet .", "label": "", "metadata": {}, "score": "42.873047"}
{"text": "In 2 studies , healthy volunteers were administered a single oral dose of fenofibric acid or fenofibrate under fasting or fed conditions .The 90 % CIs were within the 80 % to 125 % limits for pharmacokinetic parameters both in fasted and fed conditions , demonstrating bioequivalence for these doses .", "label": "", "metadata": {}, "score": "43.146366"}
{"text": "This study suggests that when formulations are bioequivalent , a generic may be substituted for a name brand formulation , as long as the doses are taken without food .", "label": "", "metadata": {}, "score": "43.203445"}
{"text": "The test ( dispersible ) and reference tablets met the regulatory criteria for bioequivalence as defined by the SFDA .Both formulations were well tolerated .", "label": "", "metadata": {}, "score": "43.219852"}
{"text": "Since food may affect the absorption and dissolution of the drug and which in turn increased the variability of the PK parameters .In order to avoid such circumstances food with uniform calorie content was supplied to each of the volunteers during study period .", "label": "", "metadata": {}, "score": "43.307133"}
{"text": "This property proves a superiority of gliclazide MR to the conventional tablets where the variation in bioavailability is commonly reported [ 10 ] .Gliclazide MR shows linear pharmacokinetic properties over the dose range of 15 - 120 mg and low individual variability at 16 % [ 8 ] .", "label": "", "metadata": {}, "score": "43.345116"}
{"text": "Adverse experiences have been limited to those that were reported previously with losartan potassium and/or hydrochlorothiazide .The overall incidence of adverse experiences reported with the combination was comparable to placebo .", "label": "", "metadata": {}, "score": "43.524204"}
{"text": "The results of this study demonstrated that the test product , Glycon MR , and the reference product , Diamicron MR were bioequivalent and may be used as an evidence for physicians to select the more cost - effective preparation of the modified - release gliclazide tablets .", "label": "", "metadata": {}, "score": "43.641777"}
{"text": "Geriatric Use .In an effort to control blood pressure in this study , patients were coadministered losartan and hydrochlorothiazide 74 % of the total time they were on study drug .", "label": "", "metadata": {}, "score": "43.859802"}
{"text": "However , even when a food effect is not evident , absorption can be affected by differences in gastrointestinal transit and residence times .Although some fenofibrate treatment regimens still require dosing with food , finding a formulation that can be administered independently may provide greater convenience for patients .", "label": "", "metadata": {}, "score": "44.059433"}
{"text": "The 90 % confidence intervals were within the acceptance criteria of 0.80 - 1.25 regardless of the food effect , indicating bioequivalence between the two products on the rate and extent of gliclazide MR absorption without regard to meals .", "label": "", "metadata": {}, "score": "44.150146"}
{"text": "Koh KK , Quon MJ , Han SH , Chung WJ , Ahn JY , Seo YH , Choi IS , et al .Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia .", "label": "", "metadata": {}, "score": "44.15113"}
{"text": "In the LIFE study , Black patients with hypertension and left ventricular hypertrophy had a lower risk of stroke on atenolol than on losartan ( both cotreated with hydrochlorothiazide in the majority of patients ) .", "label": "", "metadata": {}, "score": "44.198204"}
{"text": "Together , the comparative clinical trials in this review highlight the importance of the relationship between fenofibrate formulation and bioequivalence , food effects , and overall efficacy .", "label": "", "metadata": {}, "score": "44.322792"}
{"text": "The addition of a fibrate to statin therapy offers the potential to substantially lower LDL - C and triglycerides and to elevate HDL - C. To date , only fenofibric acid ( Trilipix \u00ae ) has been approved by the FDA for coadministration with a statin [ 22 ] .", "label": "", "metadata": {}, "score": "44.580406"}
{"text": "A single dose two period , 2 sequence , 2 treatment cross - over study with a minimum wash - out period of 7 days was carried out in fasting conditions for alfuzosin formulation ( FDA Guidelines , 2005 ) .", "label": "", "metadata": {}, "score": "44.61953"}
{"text": "In a single - dose study in normal volunteers , losartan had no effects on glomerular filtration rate , renal plasma flow or filtration fraction .", "label": "", "metadata": {}, "score": "44.681854"}
{"text": "A once - daily formulation , which delivers alfuzosin via a novel prolonged - release system , has been developed to improve the convenience of dosing and to provide optimal pharmacokinetic coverage over 24 h [ 14 , 15 ] .", "label": "", "metadata": {}, "score": "44.698975"}
{"text": "Intervention : Drug : Fosinopril sodium and hydrochlorothiazide 20 - 12.5 mg tablets .Active Comparator : 2 .Monopril \u00ae .-HCT 20 - 12.5 mg tablets by Bristol - Meyers Squibb following a single oral dose ( 1 x 20 - 12.5 mg tablet .", "label": "", "metadata": {}, "score": "44.91748"}
{"text": "Moreover , adhering to a low - fat diet as part of lipid - modifying therapy [ 2 , 42 ] may compromise fenofibrate bioavailability in some currently available fenofibrate formulations .", "label": "", "metadata": {}, "score": "44.9579"}
{"text": "Losartan potassium was negative in the microbial mutagenesis and V-79 mammalian cell mutagenesis assays and in the in vitro alkaline elution and in vitro and in vivo chromosomal aberration assays .", "label": "", "metadata": {}, "score": "45.14116"}
{"text": "Therefore the aim of the present formulation development was to prepare control release alfuzosin 10 mg tablets by hot - melt extrusion process with the use of mono- and diglycerol as a rate controlling membrane .", "label": "", "metadata": {}, "score": "45.148804"}
{"text": "4 , pp .185 - 191 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Delrat , M. Paraire , and R. Jochemsen , \" Complete bioavailability and lack of food - effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers , \" Biopharmaceutics and Drug Disposition , vol .", "label": "", "metadata": {}, "score": "45.196068"}
{"text": "Hence it was concluded that mono- and diglycerides , lactose monohydrate , colloidal silicon dioxide , magnesium stearate , and talc were compatible with alfuzosin hydrochloride in the formulation .", "label": "", "metadata": {}, "score": "45.200874"}
{"text": "Adverse events were somewhat more frequent in the elderly compared to non - elderly patients for both the losartan - hydrochlorothiazide and the control groups ( see CLINICAL PHARMACOLOGY , Special Populations ) .", "label": "", "metadata": {}, "score": "45.386723"}
{"text": "Since safety of the test formulation was better than the reference in the study , proposed changes in the formulation are acceptable and inactive ingredients used for the development of the formulations were safe .", "label": "", "metadata": {}, "score": "45.523315"}
{"text": "In this review , we compare the key , clinically relevant characteristics of the fenofibrate formulations that are currently available , specifically focusing on comparative studies examining the bioavailability , food effects , and absorption of these fenofibrate formulations .", "label": "", "metadata": {}, "score": "45.646324"}
{"text": "Due to its lipophilicity , drug absorption is limited by the ability of the drug to be released from the dosage form .Immediate release preparations of gliclazide have been marketed for a long time with the general administration of twice daily taken with the main meals .", "label": "", "metadata": {}, "score": "45.78199"}
{"text": "The relationship of these findings to drug - treatment is uncertain since there was no effect at these dosage levels on implants / pregnant female , percent post - implantation loss , or live animals / litter at parturition .", "label": "", "metadata": {}, "score": "45.794426"}
{"text": "The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined .Subjects who do not metabolize losartan to active metabolite have been shown to have a specific , rare defect in cytochrome P450 2C9 .", "label": "", "metadata": {}, "score": "45.855133"}
{"text": "Differences in bioavailability of fenofibrate formulations have resulted in low - dose ( 40 - 67 ) mg and standard - dose ( 120 - 200 mg ) formulations .", "label": "", "metadata": {}, "score": "45.91221"}
{"text": "As per bioequivalence guideline , [ 33 , 36 ] 90 % CI will be constructed , which will be predefined values of 80 to 125 % of the reference drug in log scale to establish generic equivalence .", "label": "", "metadata": {}, "score": "46.12804"}
{"text": "Together , the complications introduced by food and fat effects on bioavailability of currently marketed fenofibrate products emphasize the importance of careful consideration of consequences when switching patients from one fenofibrate formulation to another .", "label": "", "metadata": {}, "score": "46.141373"}
{"text": "Thus , although this study suggested differences in bioequivalence under the fasting and fed states , efficacy was less affected by administration with food and formed the basis for the indication to administer the drug without regard to meals .", "label": "", "metadata": {}, "score": "46.231617"}
{"text": "A compatibility study of the drug with the selected impurities was conducted for the period of 30 days at 50 \u00b0 C .The analysis of the relative impurity was observed to find out the incompatibility .", "label": "", "metadata": {}, "score": "46.274803"}
{"text": "T : .Test formulation .USP : .United State pharmacopoeia .ALT : .Alanine transaminase .AST : .Aspartate aminotransferase .RIA : .", "label": "", "metadata": {}, "score": "46.383545"}
{"text": "Jones PH , Davidson MH , Kashyap ML , Kelly MT , Buttler SM , Setze CM , Sleep DJ , et al .Efficacy and safety of ABT-335 ( fenofibric acid ) in combination with rosuvastatin in patients with mixed dyslipidemia : a phase 3 study .", "label": "", "metadata": {}, "score": "46.402565"}
{"text": "Test formulation .Active Comparator : Reference formulation .Reference product : Amoxil \u00ae 500mg/5mL powder for oral suspension in Period 1 ; followed by 14-days washout period during which no medication was administered ; followed by test product : Amoxicillin powder for oral suspension ( Clamoxyl \u00ae ) 500mg/5mL in Period 2 .", "label": "", "metadata": {}, "score": "46.433342"}
{"text": "With respect to international guidelines for bioequivalence study , the effect of food should be approved [ 12 , 13 ] .In this current work , we originate the bioequivalence study of two gliclazide MR , Glycon MR , and Diamicron MR , in healthy Thai volunteers in both fasted and fed conditions .", "label": "", "metadata": {}, "score": "46.43789"}
{"text": "54 - 61 , 1989 .View at Google Scholar .N. D. Eddington , G. S. Rekhi , L. J. Lesko , and L. L. Augsburger , \" Scale - up effects on dissolution and bioavailability of propranolol hydrochloride and metaprolol tartrate tablet formulations , \" AAPS PharmSciTech , vol .", "label": "", "metadata": {}, "score": "46.44918"}
{"text": "Afterwards ten formulations were processed based on the in vitro parameters as mentioned in the reference drug .A batch formulation of the drug was also generated for further evaluations in the commercial scale .", "label": "", "metadata": {}, "score": "46.48353"}
{"text": "The safety and tolerability of both the formulations was comparable .Adverse events were assessed for severity and relationship to the treatments throughout the study .", "label": "", "metadata": {}, "score": "46.601746"}
{"text": "Thus , formulations with Lidose \u00ae technology may have greater bioavailability than MF under certain conditions , but not others .Limited evidence suggests that generic fenofibrate products with the same formulation may be bioequivalent under fasting conditions .", "label": "", "metadata": {}, "score": "46.61205"}
{"text": "Increases in cholesterol and triglyceride levels may be associated with thiazide diuretic therapy .Impaired Renal Function .As a consequence of inhibiting the renin - angiotensin - aldosterone system , changes in renal function have been reported in susceptible individuals treated with losartan ; in some patients , these changes in renal function were reversible upon discontinuation of therapy .", "label": "", "metadata": {}, "score": "46.69777"}
{"text": "Zhu and colleagues compared the gastrointestinal absorption characteristics and absolute bioavailability of fenofibric acid ( 130 mg oral suspension ) and nanocrystal fenofibrate ( 145 mg oral suspension ) administered at least 4 hours after a light breakfast in healthy volunteers [ 40 ] .", "label": "", "metadata": {}, "score": "46.737762"}
{"text": "The compositions of various batches preparation is given in Table 1 .In Vitro Assay and Content Uniformity Test .Preparation of Standard Drug Samples 20 mg of alfuzosin hydrochloride working standard was dissolved in 75 mL of mobile phase ( mixture of buffer ( pH 3.5 ) : acetonitrile at a ratio of 4 : 1 ) using sonication . 10.0 mL of this solution was mixed with 50.0 mL mobile phase ( mixture of buffer ( pH 3.5 ) : acetonitrile at a ratio of 4 : 1 ) .", "label": "", "metadata": {}, "score": "46.808712"}
{"text": "However , the greater bioavailability obtained with the Lidose \u00ae technology relative to MF may be compromised by food effects .Absorption of a fenofibrate formulation ( Lipofen \u00ae ; Fig .", "label": "", "metadata": {}, "score": "46.810364"}
{"text": "Combining fenofibrate with a statin is a therapeutic option to address these additional lipid abnormalities .However , subsequent meta - analyses ( which incorporated these same studies ) have highlighted the lipid - modifying benefit of fibrate treatment in patients with elevated triglycerides and low HDL - C [ 60 - 62 ] .", "label": "", "metadata": {}, "score": "46.825275"}
{"text": "Standard Preparation 25 mg of Alfuzosin hydrochloride working standard was transferred to a 100 mL volumetric flask and dissolved in methanol by sonication .Then 2.0 mL of this solution was diluted to 100.0 mL with diluents ( methanol ) for analysis by spectrophotometer with a . of 244 nm .", "label": "", "metadata": {}, "score": "46.82769"}
{"text": "The test product gave slightly greater AUC with higher .Figure 1 : Mean plasma concentration of gliclazide after administration of 30 mg gliclazide MR tablets of the test product , Glycon MR , and the reference product , Diamicron MR , in 18 volunteers under fasted condition . of the test product compared to the reference product under fasted and fed conditions .", "label": "", "metadata": {}, "score": "46.85373"}
{"text": "This parameter is estimated via linear regression of time versus log concentration .Test product : Amoxicillin powder for oral suspension ( Clamoxyl \u00ae ) 500mg/5mL in Period 1 ; followed by 14-days washout period during which no medication was administered ; followed by reference product : Amoxil \u00ae 500mg/5mL in Period 2 .", "label": "", "metadata": {}, "score": "46.868225"}
{"text": "In a literature search of the key term enoxaparin ( publication years not restricted ) , no published data were identified regarding the pharmacokinetic profile of generic enoxaparin in Chinese subjects .", "label": "", "metadata": {}, "score": "46.900085"}
{"text": "Despite the promise of these combination therapies , studies examining the use of fenofibrate or fenofibric acid with high - dose statin therapy have yet to be completed , and at least for now , these combinations should be avoided .", "label": "", "metadata": {}, "score": "46.944695"}
{"text": "Related Drugs .Comparative bioavailability of two irbesartan / hydrochlorothiazide tablet formulations in Indonesian healthy subjects .Author(s ) : Sasongko L , Harahap Y , Prasaja B , Lusthom W , Setiawan EC , Meliala RS , Lipin .", "label": "", "metadata": {}, "score": "46.973167"}
{"text": "An oral dispersible tablet formulation of risperidone has been developed .This study was conducted to provide support for marketing authorization of this drug in China .", "label": "", "metadata": {}, "score": "47.173843"}
{"text": "Thus , long - term efficacy and safety studies are still necessary to establish the benefits of this particular combination drug .Discussion .Although statins are effective at lowering LDL - C , their efficacy on other lipid targets , specifically HDL - C and triglycerides , is less substantial .", "label": "", "metadata": {}, "score": "47.18872"}
{"text": "Other antihypertensive drugs - additive effect or potentiation .Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .", "label": "", "metadata": {}, "score": "47.30651"}
{"text": "The PK study results revealed that the two formulations of alfuzosin were similar in PK characteristics among these healthy Indian subjects under fasting conditions .The 90 % confidence intervals of log transformed PK metrics for the ratio of .", "label": "", "metadata": {}, "score": "47.331635"}
{"text": "Short - term efficacy and safety studies suggest that AtorFen \u00ae generally led to greater decreases in triglycerides and greater increases in HDL - C than either atorvastatin or fenofibrate alone [ 59 ] .", "label": "", "metadata": {}, "score": "47.378128"}
{"text": "In long - term follow - up studies ( without placebo control ) the effect of losartan appeared to be maintained for up to a year .", "label": "", "metadata": {}, "score": "47.570404"}
{"text": "Abstract .In this review , the key characteristics of available fenofibrate formulations are examined .A literature search was conducted , focusing on comparative studies examining bioavailability , food effects , absorption , and lipid efficacy .", "label": "", "metadata": {}, "score": "47.59279"}
{"text": "Losartan does not affect the response to bradykinin , whereas ACE inhibitors increase the response to bradykinin .Aldosterone plasma concentrations fall following losartan administration .", "label": "", "metadata": {}, "score": "47.621197"}
{"text": "Carcinogenesis , Mutagenesis , Impairment of Fertility .Losartan Potassium - Hydrochlorothiazide .No carcinogenicity studies have been conducted with the losartan potassium - hydrochlorothiazide combination .", "label": "", "metadata": {}, "score": "47.623184"}
{"text": "There is evidence that this product is better absorbed with a high - fat meal ; when administered with a high - fat meal , there was a 26 % increase in fenofibric acid bioavailability and a 108 % increase in maximum concentration compared with the fasting state [ 29 ] .", "label": "", "metadata": {}, "score": "47.694824"}
{"text": "Resolution Solution 20 mg of alfuzosin hydrochloride working standard and 20 mg of impurity A standard was mixed with 75 mL diluents and made to 100 mL after sonication . 1.0 mL of this solution was diluted to 100.0 mL and injected to HPLC .", "label": "", "metadata": {}, "score": "47.77236"}
{"text": "This study was aimed to investigate bioequivalence of modified - release 30 mg gliclazide tablets in 18 healthy Thai volunteers .A test product , Glycon MR ( Siam Bheasach , TH ) , was compared with a reference product , Diamicron MR ( Servier , France ) .", "label": "", "metadata": {}, "score": "47.79927"}
{"text": "40 meshes passed talc for 15.0 min and then lubricated with magnesium separate no .40 mesh ( presifted ) for 5.0 min .Six different concentrations of rate controlling agents were formulated in six different tablets formulations of same hardness and dissolution of all formulations were carried out using USP dissolution apparatus type II under nonsink conditions in 900 mL HCl ( 0.1 N ) .", "label": "", "metadata": {}, "score": "47.826378"}
{"text": "Cardiovasc Drugs Ther . doi pubmed .Davidson MH , Rooney MW , Drucker J , Eugene Griffin H , Oosman S , Beckert M. Efficacy and tolerability of atorvastatin / fenofibrate fixed - dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia : a 12-week , multicenter , double - blind , randomized , parallel - group study .", "label": "", "metadata": {}, "score": "48.006416"}
{"text": "Allocation : Randomized Endpoint Classification : Bio - equivalence Study Intervention Model : Crossover Assignment Masking : Open Label .Official Title : .Evaluation of Pharmaceutical Bioequivalence of Amoxicillin Trihydrate - Clamoxyl 500mg/5mL ( Glaxo Wellcome Production . ) in the Form Powder for Oral Suspension Versus Amoxil \u00ae 500mg/5mL ( GlaxoSmithKline Mexico SA ) in the Form of Powder for Oral Suspension in Healthy Volunteers and Fasting , Using Techniques of Liquid Chromatography .", "label": "", "metadata": {}, "score": "48.00879"}
{"text": "A somewhat greater interaction ( approximately 40 % reduction in the AUC of active metabolite and approximately 30 % reduction in the AUC of losartan ) has been reported with rifampin .", "label": "", "metadata": {}, "score": "48.05562"}
{"text": "Finally , the method was successfully applied to a bioequivalence study of a single 500 mg dose of cefuroxime axetil in 22 healthy Chinese male subjects under fasting condition .", "label": "", "metadata": {}, "score": "48.072662"}
{"text": "Superficial peeling of palms and hemolysis were reported in one subject treated with losartan potassium .Losartan Potassium .Other adverse experiences that have been reported with losartan , without regard to causality , are listed below : .", "label": "", "metadata": {}, "score": "48.096813"}
{"text": "Although non - adherence to the food and fat requirements seen with currently marketed fenofibrate formulations can clearly lead to inconsistent , unpredictable , and suboptimal pharmacokinetics , few studies have actually compared the influence of food effects on the lipid - lowering efficacy of these products .", "label": "", "metadata": {}, "score": "48.148643"}
{"text": "Fertility and reproductive performance were not affected in studies with male rats given oral doses of losartan potassium up to approximately 150 mg / kg / day .", "label": "", "metadata": {}, "score": "48.20249"}
{"text": "Volunteers with known contraindication or hypersensitivity to gliclazide were excluded as well as those with known history of drug abuse , alcohol consumer , or cigarette smokers .", "label": "", "metadata": {}, "score": "48.275352"}
{"text": "In final conclusion , the results suggested that the scale - up of highly permeable and highly soluble drugs did not significantly affect either in vitro dissolution or in vivo performance .", "label": "", "metadata": {}, "score": "48.28797"}
{"text": "The double - blind treatment period lasted up to 8 weeks .The incidence of cough is shown below .These studies demonstrate that the incidence of cough associated with losartan therapy , in a population that all had cough associated with ACE - inhibitor therapy , is similar to that associated with hydrochlorothiazide or placebo therapy .", "label": "", "metadata": {}, "score": "48.327164"}
{"text": "Results .Formulation .Drug excipients compatibility study was carried out to find out status of impurities present in the formulation ( Table S2 in Supplementary Material ) .", "label": "", "metadata": {}, "score": "48.35078"}
{"text": "Hydrochlorothiazide : Following oral administration , the AUC for hydrochlorothiazide is increased by 70 and 700 % for patients with mild and moderate renal insufficiency , respectively .", "label": "", "metadata": {}, "score": "48.457703"}
{"text": "The volunteers received , in each period , the reference or the test formulation , according to the randomization list , under fasting conditions .The comparative bioavailability of the two formulations was evaluated based in statistical comparisons of relevant pharmacokinetic parameters , obtained from data of drug concentrations in blood .", "label": "", "metadata": {}, "score": "48.65079"}
{"text": "Maciejewski S , Hilleman D. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia .", "label": "", "metadata": {}, "score": "48.692337"}
{"text": "Although these data point to the potential benefit of fenofibrate treatment in the subpopulation with mixed dyslipidemia , no published clinical study to date has tested the effect .", "label": "", "metadata": {}, "score": "48.762737"}
{"text": "It is important to note that differences in food effects seen with various fenofibrate and fenofibric acid formulations can alter a patient ' s adherence to treatment .", "label": "", "metadata": {}, "score": "48.802216"}
{"text": "Nursing Mothers .It is not known whether losartan is excreted in human milk , but significant levels of losartan and its active metabolite were shown to be present in rat milk .", "label": "", "metadata": {}, "score": "48.805794"}
{"text": "Biliary excretion contributes to the elimination of losartan and its metabolites .Following oral 14 C - labeled losartan , about 35 % of radioactivity is recovered in the urine and about 60 % in the feces .", "label": "", "metadata": {}, "score": "48.820858"}
{"text": "Although all 3 fibrate formulations were similarly well tolerated , these studies clearly show that they are not bioequivalent when dosed with a high - fat meal and , in some cases , on an empty stomach .", "label": "", "metadata": {}, "score": "48.90126"}
{"text": "The recovery of the internal standard was about 68 % ( Table 3 ) .The generic alfuzosin HCl 10 mg ER tablets was prepared using mono- and diglyceride as oppose to the innovator formulation containing HPMC and ethyl cellulose .", "label": "", "metadata": {}, "score": "48.918808"}
{"text": "CONCLUSION :These results indicated that the two formulations of irbesartan / hydrochlorothiazide were bioequivalent ; therefore they may be prescribed interchangeably .The submission has NOT been previously published , nor is it before another journal for consideration .", "label": "", "metadata": {}, "score": "48.981583"}
{"text": "The finished products were tested as it was tested for the raw API .The recovery of the impurities and relative retention factor ( Table S2 in Supplementary Material ) were less than 2 % which indicated that the tablets met regulatory requirement of stability at the finished product .", "label": "", "metadata": {}, "score": "49.022526"}
{"text": "All the above parameters were kept constant of the pilot and pivotal batches of the formulations except screen size was increased to 1.2 mm instead of 0.8 mm [ 24 ] ( Table S1 in Supplementary Material ) .", "label": "", "metadata": {}, "score": "49.027393"}
{"text": "Adverse events were somewhat more frequent in the elderly compared to non - elderly patients and somewhat more frequent in Blacks compared to non - Blacks for both the losartan - hydrochlorothiazide and the control groups .", "label": "", "metadata": {}, "score": "49.11001"}
{"text": "Pivotal Batch of Alfuzosin Hydrochloride Tablets The pivotal batch of alfuzosin hydrochloride ER tablets 10 mg was planned to make 130,000 tablets .The hot - melt granulation was carried out in 25 L jacketed Rapid Mixer Granulator involving granulation in 3 lots , cooling in 3 lots , sifting , milling followed by blending and lubrication in 1 lot [ 27 , 28 ] .", "label": "", "metadata": {}, "score": "49.13524"}
{"text": "Regardless of when therapy is initiated in patients with dyslipidemia , fenofibrate has been shown to significantly reduce serum total cholesterol , LDL - C , and triglycerides , and to increase HDL - C [ 8 , 12 - 14 ] .", "label": "", "metadata": {}, "score": "49.15811"}
{"text": "Other adverse experiences that have been reported with hydrochlorothiazide , without regard to causality , are listed below : .Persistent dry cough ( with an incidence of a few percent ) has been associated with ACE - inhibitor use and in practice can be a cause of discontinuation of ACE - inhibitor therapy .", "label": "", "metadata": {}, "score": "49.309395"}
{"text": "Total plasma clearance of losartan and the active metabolite is about 600 mL / min and 50 mL / min , respectively , with renal clearance of about 75 mL / min and 25 mL / min , respectively .", "label": "", "metadata": {}, "score": "49.31655"}
{"text": "General .Losartan Potassium .Losartan is an orally active agent that undergoes substantial first - pass metabolism by cytochrome P450 enzymes .It is converted , in part , to an active carboxylic acid metabolite that is responsible for most of the angiotensin II receptor antagonism that follows losartan treatment .", "label": "", "metadata": {}, "score": "49.438263"}
{"text": "doi pubmed .Godfrey AR , Digiacinto J , Davis MW .Single - dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions : a report of two phase I , open - label , single - dose , randomized , crossover clinical trials .", "label": "", "metadata": {}, "score": "49.52964"}
{"text": "The linear plasma concentration ( mean \u00b1 SD ) versus time curves of 2 alfuzosin formulations applied to 35 subjects under fasting conditions are given in Figure 2 .", "label": "", "metadata": {}, "score": "49.70037"}
{"text": "N Engl J Med . doi pubmed .Athyros VG , Papageorgiou AA , Athyrou VV , Demitriadis DS , Kontopoulos AG .Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia .", "label": "", "metadata": {}, "score": "49.707447"}
{"text": "Guichard JP , Blouquin P , Qing Y. A new formulation of fenofibrate : suprabioavailable tablets .Curr Med Res Opin . pubmed .Guivarc'h PH , Vachon MG , Fordyce D. A new fenofibrate formulation : results of six single - dose , clinical studies of bioavailability under fed and fasting conditions .", "label": "", "metadata": {}, "score": "49.735596"}
{"text": "Bays HE , Jones PH , Mohiuddin SM , Kelly MT , Sun H , Setze CM , Buttler SM , et al .Long - term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia .", "label": "", "metadata": {}, "score": "49.743683"}
{"text": "Goldberg AC , Bays HE , Ballantyne CM , Kelly MT , Buttler SM , Setze CM , Sleep DJ , et al .Efficacy and safety of ABT-335 ( fenofibric acid ) in combination with atorvastatin in patients with mixed dyslipidemia .", "label": "", "metadata": {}, "score": "49.802235"}
{"text": "This single - dose , randomized - sequence , open - label , 2-period crossover study involved 22 healthy male Chinese volunteers .Equal numbers of eligible participants were randomly assigned to receive either the test drug ( 2 mg ) or the same dose of the reference formulation , followed by a 2-week washout period and administration of the alternate formulation .", "label": "", "metadata": {}, "score": "49.907104"}
{"text": "pubmed .Vlase L , Popa A , Muntean D , Leucuta SE .Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers .", "label": "", "metadata": {}, "score": "49.95669"}
{"text": "Conversion of losartan to its active metabolite after intravenous administration is not affected by ketoconazole , an inhibitor of P450 3A4 .The AUC of active metabolite following oral losartan was not affected by erythromycin , another inhibitor of P450 3A4 , but the AUC of losartan was increased by 30 % .", "label": "", "metadata": {}, "score": "50.079826"}
{"text": "Comparative clinical trials of fenofibrate formulations .Bioavailability and food effects .Since fenofibrate was first introduced , the main limitation has been the low bioavailability when taken orally , especially without a high - fat meal .", "label": "", "metadata": {}, "score": "50.17092"}
{"text": "Coadministration with meals was necessary to maximize bioavailability of early formulations .Micronized and nanoparticle formulations of fenofibrate with reduced particle sizes were developed , resulting in greater solubility , improved bioavailability , and in some cases , the ability to be given irrespective of food .", "label": "", "metadata": {}, "score": "50.198597"}
{"text": "Article copyright , the authors ; Journal compilation copyright , the Cardiol Res and Elmer Press TM .A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations .", "label": "", "metadata": {}, "score": "50.318504"}
{"text": "Reports suggest that NSAIDs including selective COX-2 inhibitors may diminish the antihypertensive effect of angiotensin II receptor antagonists , including losartan .This interaction should be given consideration in patients taking NSAIDs including selective COX-2 inhibitors concomitantly with angiotensin II receptor antagonists .", "label": "", "metadata": {}, "score": "50.349957"}
{"text": "The pharmacokinetic parameters were determined from the plasma concentration and time data using a noncompartmental analysis by WinNonlin professional software ( Version : 5.3 ; Pharsight Corporation , USA ) .", "label": "", "metadata": {}, "score": "50.53447"}
{"text": "Partly because it is desirable to limit high - fat meals in patients with hypertriglyceridemia , for which fenofibrate is often prescribed [ 2 ] ( 2 ) , studies of newer formulations of fenofibrate have examined whether these drugs can be taken without food .", "label": "", "metadata": {}, "score": "50.618637"}
{"text": "In addition 900 mL of dissolution media each of 0.1 N HCl ( pH 1.2 ) , acetate buffer ( pH 4.5 ) , and phosphate buffer ( pH 6.8 ) were used to compare final scale up formulation with innovator formulation .", "label": "", "metadata": {}, "score": "50.711388"}
{"text": "HYZAAR is not recommended as initial therapy in patients with hepatic impairment ( see WARNINGS , Impaired Hepatic Function ) because the appropriate 25 mg starting dose of losartan can not be given .", "label": "", "metadata": {}, "score": "50.744087"}
{"text": "The in vivo pharmacokinetic parameters under fasting conditions between test and reference formulations ( Uroxatral 10 mg extended release tablets ) were comparable .The 90 % CI , geometric mean ratio ( % ) and power of . , AUCT , and AUCI of the fasting study for the test and reference formulation were 99.03 % to 122.78 % , 109 % , 0.998 ; 92.94 % to 116.71 % , 104 % , 1 ; 98.17 % to 124.01 % , 110 % 1 , respectively .", "label": "", "metadata": {}, "score": "50.768784"}
{"text": "Sauron R , Wilkins M , Jessent V , Dubois A , Maillot C , Weil A. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation .", "label": "", "metadata": {}, "score": "50.796852"}
{"text": "Drug clearance is 0.9 L / h with the distribution volume of 19 L. An initial recommended dose is 30 mg once daily taken with breakfast , and the daily dose can be monitored in the range of 30 - 120 mg .", "label": "", "metadata": {}, "score": "50.88174"}
{"text": "Non - steroidal Anti - inflammatory Drugs including Selective Cyclooxygenase -2 Inhibitors - In some patients , the administration of a non - steroidal anti - inflammatory agent including a selective cyclooxygenase-2 inhibitor can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium - sparing and thiazide diuretics .", "label": "", "metadata": {}, "score": "50.91088"}
{"text": "Hydrochlorothiazide .The oral LD 50 of hydrochlorothiazide is greater than 10 g / kg in both mice and rats .The most common signs and symptoms observed are those caused by electrolyte depletion ( hypokalemia , hypochloremia , hyponatremia ) and dehydration resulting from excessive diuresis .", "label": "", "metadata": {}, "score": "50.972427"}
{"text": "Although elimination of a positive food effect simplifies dosing , it is still unclear whether the improvements in lipid parameters were due to increased bioavailability or increased patient compliance .", "label": "", "metadata": {}, "score": "50.98487"}
{"text": "There are 2 bioequivalent formulations available [ 8 ] : an immediate release form ( 2.5 mg , 3 times daily ) and a sustained - release form ( 5 mg , 2 times daily and 10 mg once daily ) .", "label": "", "metadata": {}, "score": "51.007095"}
{"text": "The mixture equivalent to 20 mg of the drug was transferred into 100 mL volumetric flask containing 75 mL of mobile phase and sonicated to dissolve .", "label": "", "metadata": {}, "score": "51.024933"}
{"text": "Under low - fat fed conditions , all 3 formulations were bioequivalent ( 90 % CIs within the 80 - 125 % bioequivalence range ) .", "label": "", "metadata": {}, "score": "51.05091"}
{"text": "Except for generic equivalents of a specific branded product , fenofibrate formulations are not bioequivalent , and should not be treated as such .Acknowledgement .", "label": "", "metadata": {}, "score": "51.12648"}
{"text": "Impaired Hepatic Function .Losartan Potassium - Hydrochlorothiazide .HYZAAR is not recommended for patients with hepatic impairment who require titration with losartan .The lower starting dose of losartan recommended for use in patients with hepatic impairment can not be given using HYZAAR .", "label": "", "metadata": {}, "score": "51.184"}
{"text": "583 , no . 2 , pp .266 - 269 , 1992 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus HYZAAR - losartan potassium and hydrochlorothiazide tablet , film coated Merck & Co. , Inc. .", "label": "", "metadata": {}, "score": "51.297295"}
{"text": "22 mg of alfuzosin hydrochloride working standard was dissolved in 5 mL methanol and made the volume up to 200 mL with dissolution medium .20-fold diluted sample was injected to instrument for analysis .", "label": "", "metadata": {}, "score": "51.30327"}
{"text": "The event rate was slightly higher ( 17 % ) in patients with diabetes [ 9 , 10 ] .Moreover , Fruchart and colleagues reported that the percentage of residual relative risk after statin monotherapy ranges from 63 % to 91 % [ 11 ] .", "label": "", "metadata": {}, "score": "51.393723"}
{"text": "These benefits were maintained for up to 2 years in an open - label extension study of the combination therapies [ 56 ] .Improvements also were evident with combination therapy in a post hoc analysis of patients with type 2 diabetes mellitus [ 57 ] who comprised subsets of the populations in two 12-week controlled studies mentioned previously [ 52 , 55 ] .", "label": "", "metadata": {}, "score": "51.39747"}
{"text": "These studies are consistent with the findings of Zhu and colleagues from the gastrointestinal study discussed previously , which demonstrated that fenofibric acid had greater absorption versus fenofibrate throughout the gastrointestinal tract and has improved bioavailability .", "label": "", "metadata": {}, "score": "51.423904"}
{"text": "7 - 9 , 1990 .View at Google Scholar \u00b7 View at Scopus .J. F. Yang , G. L. Wei , R. Lu , C. X. Liu , B. Z. Zheng , and P. Feng , \" Bioavailability of gliclazide sustained release tablet in healthy volunteers , \" Asian Journal of Pharmacodynamics and Pharmacokinetics , vol .", "label": "", "metadata": {}, "score": "51.44137"}
{"text": "Full Prescribing Information , Ranbaxy Pharmaceuticals Inc , Jacksonville , FL , 2009 .Keech A , Simes RJ , Barter P , Best J , Scott R , Taskinen MR , Forder P , et al .", "label": "", "metadata": {}, "score": "51.44801"}
{"text": "For the most part , adverse experiences have been mild and transient in nature and have not required discontinuation of therapy .In controlled clinical trials , discontinuation of therapy due to clinical adverse experiences was required in only 2.8 % and 2.3 % of patients treated with the combination and placebo , respectively .", "label": "", "metadata": {}, "score": "51.462"}
{"text": "pubmed .Zhu T , Ansquer JC , Kelly MT , Sleep DJ , Pradhan RS .Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans .", "label": "", "metadata": {}, "score": "51.510338"}
{"text": "Sample Preparation The alfuzosin hydrochloride was weighed accurately in a 100 mL volumetric flask containing 10 mL alcohol and was sonicated for 30 min with occasional shaking .", "label": "", "metadata": {}, "score": "51.581627"}
{"text": "This method has been successfully applied in clinical pharmacokinetic and bioequivalence analyses .No preview \u00b7 Article \u00b7 Jun 2012 \u00b7 Journal of pharmaceutical and biomedical analysis .", "label": "", "metadata": {}, "score": "51.62989"}
{"text": "Then 20 mL of the above solution was diluted to 50 mL with mobile phase .Procedure Separately 20 \u03bc L mobile phase , standard preparation , and sample preparation were injected into Waters HPLC system equipped with Kromasil Cl8 ( Ll ) ( .", "label": "", "metadata": {}, "score": "51.721725"}
{"text": "Several dozen cases have been reported in the world literature in patients who were taking angiotensin converting enzyme inhibitors .When pregnancy is detected , HYZAAR should be discontinued as soon as possible .", "label": "", "metadata": {}, "score": "51.77113"}
{"text": "Alfuzosin MR tablet was developed by the use of hot - melt granulation techniques using mono- and diglycerides as rate controlling membranes to minimize health care cost and uses of costly excipients .", "label": "", "metadata": {}, "score": "51.79963"}
{"text": "Known hypersensitivity to the study drug or to compounds chemically related .Use of experimental drug or participation in any clinical study within 6 months prior to study initiation .", "label": "", "metadata": {}, "score": "51.834774"}
{"text": "Schima SM , Maciejewski SR , Hilleman DE , Williams MA , Mohiuddin SM .Fibrate therapy in the management of dyslipidemias , alone and in combination with statins : role of delayed - release fenofibric acid .", "label": "", "metadata": {}, "score": "51.89618"}
{"text": "A meal slows absorption of losartan and decreases its C max but has only minor effects on losartan AUC or on the AUC of the metabolite ( about 10 % decreased ) .", "label": "", "metadata": {}, "score": "51.9001"}
{"text": "The closed glass vial containing physical mixture of alfuzosin hydrochloride and excipients in a particular ratio were subjected at 40 \u00b0 C/75 % RH for 4 weeks to determine the change of related substances as compared to the original API ( Active pharmaceutical agents ) .", "label": "", "metadata": {}, "score": "51.906044"}
{"text": "Fasted Condition Each volunteer randomly received a 30-mg gliclazide MR tablet either the test product or the reference product with 240-mL 20 % glucose solution after overnight fasting .", "label": "", "metadata": {}, "score": "51.943848"}
{"text": "The cumulative percent drug release of the biobatch decreased to 95 % against 96.99 % at 24 h in 0.1 N HCl ( pH 1.2 ) ( Tables S5-S10 in Supplementary Material ) [ 36 ] .", "label": "", "metadata": {}, "score": "52.02816"}
{"text": "At least 61 percent of the oral dose is eliminated unchanged within 24 hours .Hydrochlorothiazide crosses the placental but not the blood - brain barrier and is excreted in breast milk .", "label": "", "metadata": {}, "score": "52.076607"}
{"text": "The drug excipients compatibility studies were conducted and found satisfactory for intended purpose .The rate controlling polymer mono- and diglycerides had no significant impact on the impurity profile of the drug .", "label": "", "metadata": {}, "score": "52.214867"}
{"text": "Durrington PN , Tuomilehto J , Hamann A , Kallend D , Smith K. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia .", "label": "", "metadata": {}, "score": "52.251472"}
{"text": "Similar outcomes have been reported with losartan .In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis , increases in serum creatinine or BUN have been reported .", "label": "", "metadata": {}, "score": "52.253822"}
{"text": "Trilipix \u00ae ( fenofibric acid delayed release capsules ) .Full Prescribing Information , Abbott Laboratories , North Chicago , IL , 2011 .Lofibra \u00ae ( fenofibrate tablets ) .", "label": "", "metadata": {}, "score": "52.31875"}
{"text": "Results .Fenofibrate formulations currently available .Challenges with solubility led to the development of novel fenofibrate formulations ( Table 1 ) intended to increase the overall bioavailability via several different approaches ( Fig 1b ) [ 17 , 18 ] .", "label": "", "metadata": {}, "score": "52.333855"}
{"text": "163 , no .4 , supplement , pp .306 - 318 , 2000 .View at Google Scholar .L. Maggi , U. Conte , P. Gerenier et al . , \" Tablet with controlled release of alfuzosin chlorhydrate , \" US Patent 6 , 149 , 940A , 2000 .", "label": "", "metadata": {}, "score": "52.438156"}
{"text": "Full Prescribing Information , Global Pharmaceuticals , Philadelphia , PA , 2011 .Fenofibrate ( generic ) .Full Prescribing Information , Mylan Pharmaceuticals Inc , Morgantown , WV , 2010 .", "label": "", "metadata": {}, "score": "52.78273"}
{"text": "Therefore , the 2 formulations were considered to be bioequivalent .Bioequivalence Study of Modified - Release Gliclazide Tablets in Healthy Volunteers .Department of Pharmacology , Faculty of Medicine , Chiang Mai University , Chiang Mai 50200 , Thailand .", "label": "", "metadata": {}, "score": "52.834858"}
{"text": "Post - Marketing Experience .The following additional adverse reactions have been reported in post - marketing experience : .Digestive : Hepatitis has been reported rarely in patients treated with losartan .", "label": "", "metadata": {}, "score": "52.853897"}
{"text": "1a , right ) [ 22 ] .Table 1 .Fenofibrate and Fenofibric Acid Formulations Currently Available .Despite these advancements , adequate absorption of many marketed fenofibrate formulations still requires the presence of food , particularly a high - fat meal [ 21 ] .", "label": "", "metadata": {}, "score": "52.867096"}
{"text": "Significance of primary PK parameters was to draw conclusion whether a generic product can be given marketing authorization within the limit of efficacy safety and tolerability of an innovator drug .", "label": "", "metadata": {}, "score": "53.1419"}
{"text": "The onset of action of alfuzosin is rapid from the first dose and it maintains symptom relief for up to 3 years [ 11 ] .", "label": "", "metadata": {}, "score": "53.211105"}
{"text": "263 - 266 , 2009 .View at Google Scholar \u00b7 View at Scopus .X. He , K. A. Lunday , L. C. Li , and M. J. Sacchetti , \" Formulation development and process scale up of a high shear wet granulation formulation containing a poorly wettable drug , \" Journal of Pharmaceutical Sciences , vol .", "label": "", "metadata": {}, "score": "53.214073"}
{"text": "Selection of Excipients and Their Grades The grade of mono- and diglycerides used was of NF grade ( Imwitor 900 , Sasol ) .The quantity of mono- and diglycerides was used in concentrations up to 45 % as a rate controlling agent .", "label": "", "metadata": {}, "score": "53.392128"}
{"text": "It may have advantages in reducing platelet aggregation and slowing the progression of diabetic retinopathy [ 3 - 5 ] .Gliclazide is a weak acid compound with high lipophilicity and has pH - dependent solubility [ 1 ] .", "label": "", "metadata": {}, "score": "53.442825"}
{"text": "Issue Date : .Publisher : .Int J Clin Pharmacol .Abstract : .This investigation was carried out to evaluate the bioavailability of a new tablet formulation of ibuprofen ( 600 mg ) , Profinal , relative to reference product , Brufen ( 600 mg ) tablets .", "label": "", "metadata": {}, "score": "53.499016"}
{"text": "Infants with histories of in utero exposure to an angiotensin II receptor antagonist should be closely observed for hypotension , oliguria , and hyperkalemia .If oliguria occurs , attention should be directed toward support of blood pressure and renal perfusion .", "label": "", "metadata": {}, "score": "53.529976"}
{"text": "6 , pp .64 - 74 , 1996 .View at Google Scholar \u00b7 View at Scopus . \" Scientific discussion on bioequivalence aspect of Alfuzosin modified release tablets ' Merck NM ' Alfuzosin hydrochloride , \" Public Assessment Report DK / H/0899/001 - 002 , 2006 . A. Rouchouse , M. Manoha , A. Durand , and J. P. Thenot , \" Direct high - performance liquid chromatographic determination of the enantiomers of alfuzosin in plasma on a second - generation \u03b1 1-acid glycoprotein chiral stationary phase , \" Journal of Chromatography , vol .", "label": "", "metadata": {}, "score": "53.64414"}
{"text": "Good health conditions .Results of laboratory tests outside the normal limits , unless they are considered clinically irrelevant .The volunteers who underwent surgery or who were hospitalized for any reason before the start of the study will be reviewed by the physician on admission in the study , observing a period of exclusion of 4 to 8 weeks .", "label": "", "metadata": {}, "score": "53.72767"}
{"text": "Both .Ages .20 Years to 80 Years .Accepts Healthy Volunteers .No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects [ Show abstract ] [ Hide abstract ] ABSTRACT : An economical , reproducible and automated online solid - phase extraction coupled with liquid chromatography - tandem mass spectrometry method was developed to quantify methylprednisolone in human plasma .", "label": "", "metadata": {}, "score": "53.98082"}
{"text": "The 90 % CIs of the mean ratios of the plasma pharmacokinetic variables were within the conventional bioequivalence range of 80 % to 125 % [ 39 ] .", "label": "", "metadata": {}, "score": "54.072033"}
{"text": "The minimal predose blood glucose level was 75 mg / dL. The dose regimen was well tolerated in all volunteers .There was no complaint on the therapy or presence of sign and symptom of hypoglycemia .", "label": "", "metadata": {}, "score": "54.09645"}
{"text": "Thus , plasma exposure with the fenofibric acid formulation would be expected to be greater than with the nanocrystal fenofibrate formulation regardless of individual differences in the degree of motility in separate segments of the gastrointestinal tract .", "label": "", "metadata": {}, "score": "54.210663"}
{"text": "Since gliclazide MR is an oral hypoglycemia agent , blood glucose level , blood pressure , and heart rate were monitored before drug administration .The blood glucose level was determined from fingertip using FINETOUCH lancing device and MEDISAFE blood glucose meter with test tip , ( Terumo Corp.", "label": "", "metadata": {}, "score": "54.221737"}
{"text": "The reproducibility of the method was tested using various trial batches .The linearity range ( 0.050 to 30.0 ng / mL ) was fixed based upon the results of 6 trial batches .", "label": "", "metadata": {}, "score": "54.31018"}
{"text": "226 - 230 , 1994 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Harrower , \" Gliclazide modified release : from once - daily administration to 24-hour blood glucose control , \" Metabolism , vol .", "label": "", "metadata": {}, "score": "54.44271"}
{"text": "In actual salt depletion , appropriate replacement is the therapy of choice .Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy .", "label": "", "metadata": {}, "score": "54.60341"}
{"text": "at 1 h. Net / cumulative drug dissolution was calculated at each time point after adding drug present in the volume of sample taken out as correction factor .", "label": "", "metadata": {}, "score": "54.711647"}
{"text": "K3EDTA containers , disposable syringe , and ria vial were supplied by BD , India .Methods .Excipients Compatibility Screening The excipients were selected based on the results of compatibility study which were further confirmed by comparing the excipients used by reference listed drug .", "label": "", "metadata": {}, "score": "54.721416"}
{"text": "Corticosteroids , ACTH - intensified electrolyte depletion , particularly hypokalemia .Pressor amines ( e.g. , norepinephrine ) - possible decreased response to pressor amines but not sufficient to preclude their use .", "label": "", "metadata": {}, "score": "54.7323"}
{"text": "What is HYZAAR ?HYZAAR contains 2 prescription medicines , an angiotensin receptor blocker ( ARB ) and a diuretic ( water pill ) .It is used to : . lower high blood pressure ( hypertension ) .", "label": "", "metadata": {}, "score": "54.764328"}
{"text": "12 , pp .5274 - 5289 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Nair , R. Gupta , and S. Vasanti , \" In vitro controlled release of alfuzosin hydrochloride using HPMC - based matrix tablets and its comparison with marketed product , \" Pharmaceutical Development and Technology , vol .", "label": "", "metadata": {}, "score": "54.924034"}
{"text": "G. L. Amidon , H. Lennernas , V. P. Shah , and J. R. Crison , \" A theoretical basis for a biopharmaceutic drug classification : The correlation of in vitro drug product dissolution and in vivo bioavailability , \" Pharmaceutical Research , vol .", "label": "", "metadata": {}, "score": "55.24477"}
{"text": "14 - 24 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .\" Immediate Release Solid Oral Dosage Forms , Scale - Up and Postapproval Changes : Chemistry , Manufacturing and Controls :", "label": "", "metadata": {}, "score": "55.276566"}
{"text": "361 - 369 , 1986 .View at Google Scholar \u00b7 View at Scopus . \" Guidance for industry extended release oral dosage forms : development , evaluation , and application of in vitro / in vivo correlations , \" U.S. Department of Health and Human Services , Food and Drug Administration , Center for Drug Evaluation and Research ( CDER )", "label": "", "metadata": {}, "score": "55.354557"}
{"text": "Blood samples were drawn up to 48 h following drug administrations .Irbesartan and hydrochlorothiazide plasma concentrations were determined by liquid chromatography - tandem mass spectrometry method with TurboIonSpray mode .", "label": "", "metadata": {}, "score": "55.364227"}
{"text": "Alfuzosin was released from the matrix tablets by diffusion and erosion mechanisms in all of the formulations .Assay of finished tablets were between 80 to 120 % and RSD was below 10 % which indicated that the product was equivalent to USP reference standard ( Table S3 in Supplementary Material ) .", "label": "", "metadata": {}, "score": "55.43763"}
{"text": "You can ask your pharmacist or doctor for information that is written for health professionals .What are the ingredients in HYZAAR ?Active ingredients : losartan potassium , hydrochlorothiazide . microcrystalline cellulose , lactose hydrous , pregelatinized starch , magnesium stearate , hydroxypropyl cellulose , hypromellose , titanium dioxide .", "label": "", "metadata": {}, "score": "55.443466"}
{"text": "Test product of 30 mg gliclazide MR was Glycon MR ( Lot no .J6GL00930 , Siam Bheasach , Thailand , expiry 12/2008 ) and reference product was Diamicron MR ( Lot no .", "label": "", "metadata": {}, "score": "55.521126"}
{"text": "These adverse effects do not appear to have resulted from intrauterine drug exposure that has been limited to the first trimester .Mothers whose embryos and fetuses are exposed to an angiotensin II receptor antagonist only during the first trimester should be so informed .", "label": "", "metadata": {}, "score": "55.52852"}
{"text": "Moreover , many patients at risk of CHD who are taking a statin are not achieving the recommended LDL - C goals .Even when patients do reach their LDL - C goals , reduction of LDL - C alone does not always adequately reduce the risk of CVD [ 5 , 8 ] .", "label": "", "metadata": {}, "score": "55.618492"}
{"text": "Subject has acceptable ECG .Subject has no evidence of underlying disease at the pre - entry physical examination .Subject has agreed to undergo at least a 14 day washout period for prescription drugs prior to the first dosing of the study and throughout the periods of blood sample collection .", "label": "", "metadata": {}, "score": "55.72454"}
{"text": "The bioavailability was carried out on 18 healthy male volunteers who received a single dose ( 600 mg ) of the test ( T ) and the reference ( R ) products in the fasting state , in a randomized balanced 2-way crossover design .", "label": "", "metadata": {}, "score": "55.741615"}
{"text": "Treatment should be initiated with COZAAR 50 mg once daily .Hydrochlorothiazide 12.5 mg should be added or HYZAAR 50 - 12.5 substituted if the blood pressure reduction is inadequate .", "label": "", "metadata": {}, "score": "55.824253"}
{"text": "Exclusion criteria : .Participant has a history of significant multiple and/or severe allergies to ingredients of Nu - Lotan or Preminent , amlodipine or dihydropyridine drug , and thiazide drug or related drug ( i.e. , sulfonamide - containing \" chlortalidone \" medicines ) .", "label": "", "metadata": {}, "score": "56.069096"}
{"text": "The grade of talc and magnesium stearate used was of pharmaceutical grade and their quantities were chosen based on requirements .Formulation Developments In order to establish the robustness of the proposed formulation , and to optimize the rate controlling polymer concentration , the following ranges around the target formulation were investigated in the experiments .", "label": "", "metadata": {}, "score": "56.433212"}
{"text": "Severe Hypertension .There were no reported cases of syncope in either treatment group .There were 2 ( 0.6 % ) and 0 ( 0.0 % ) cases of hypotension reported in the group treated with HYZAAR and the group treated with losartan , respectively .", "label": "", "metadata": {}, "score": "56.447083"}
{"text": "DeGuzman PB , Akosah KO , Simpson AG , Barbieri KE , Megginson GC , Goldberg RI , Beller GA .Sub - optimal achievement of guideline - derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease , despite high use of evidence - based therapies .", "label": "", "metadata": {}, "score": "56.46006"}
{"text": "The quantity of alfuzosin hydrochloride ( in % ) for each location was calculated using the following formula 1 as .The results of 10 locations were taken for calculation of mean and RSD .", "label": "", "metadata": {}, "score": "56.468025"}
{"text": "Dissolution enhancement of fenofibrate by micronization , cogrinding and spray - drying : comparison with commercial preparations .Eur J Pharm Biopharm . doi pubmed .", "label": "", "metadata": {}, "score": "56.61199"}
{"text": "The parametric confidence intervals ( 90 % ) of the mean values of the pharmacokinetic characteristics ( AUC0-t , AUC0-infinity and Cmax ) for T : R ratio were in each case , well within the bioequivalence acceptable range of 80 - 125 % .", "label": "", "metadata": {}, "score": "56.6919"}
{"text": "The test product is Amoxicillin trihydrate - Clamoxyl 500mg/5mL ( Glaxo Wellcome Production . ) in the form powder for oral suspension and reference product is Amoxil \u00ae 500mg/5mL ( GlaxoSmithKline Mexico SA ) in the form of powder for oral suspension .", "label": "", "metadata": {}, "score": "56.96634"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT01431989 In Vitro - In Vivo Correlation Evaluation of Generic Alfuzosin Modified Release Tablets .", "label": "", "metadata": {}, "score": "56.982018"}
{"text": "4 , pp .151 - 157 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Ishibashi and S. Takashina , \" The effect of timing on gliclazide absorption and action , \" Hiroshima Journal of Medical Sciences , vol .", "label": "", "metadata": {}, "score": "57.00003"}
{"text": "Rarely ( probably less often than once in every thousand pregnancies ) , no alternative to an angiotensin II receptor antagonist will be found .In these rare cases , the mothers should be apprised of the potential hazards to their fetuses , and serial ultrasound examinations should be performed to assess the intra - amniotic environment .", "label": "", "metadata": {}, "score": "57.110283"}
{"text": "The subjects ' data were subjected to noncompartmental analysis to determine the pharmacokinetic properties using WinNonlin v5.3 .Log transformed pharmacokinetic data were subjected to multivariate ANOVA analysis to construct point estimate ( geometric mean ratio between test and reference ) and 90 % CI using two one - sided test to establish bioequivalence .", "label": "", "metadata": {}, "score": "57.384987"}
{"text": "In patients who are intravascularly volume - depleted ( e.g. , those treated with diuretics ) , symptomatic hypotension may occur after initiation of therapy with HYZAAR .", "label": "", "metadata": {}, "score": "57.39321"}
{"text": "Analysis of bioequivalence for two products was evaluated as well as the effect of food on the drug absorption .Materials and Methods .Study Design .", "label": "", "metadata": {}, "score": "57.414856"}
{"text": "Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals .All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance : hyponatremia , hypochloremic alkalosis , and hypokalemia .", "label": "", "metadata": {}, "score": "57.52126"}
{"text": "The following adverse events were also reported at a rate of 1 % or greater , but were as , or more , common in the placebo group in studies of essential hypertension : asthenia / fatigue , diarrhea , nausea , headache , bronchitis , pharyngitis .", "label": "", "metadata": {}, "score": "57.57342"}
{"text": "Lipofen \u00ae ( fenofibrate ) .Full Prescribing Information , Galephar Pharmaceutical Research , Juncos , PR , 2007 .Fenoglide ( fenofibrate ) .Full Prescribing Information , Sciele Pharma , Atlanta , GA , 2009 .", "label": "", "metadata": {}, "score": "57.606762"}
{"text": "Since only linear correlation is accepted for the waiver approval , hence other nonlinear regression was not applied for better correlation .Based on the IVIVC analysis acetate buffer offered highest level A correlation of 0.97 ( Figure 2(c ) ) and hence selected as a compendial media for future waiver of higher strength of same formulation without undergoing costly BE study .", "label": "", "metadata": {}, "score": "57.619232"}
{"text": "Thiazides should be used with caution in severe renal disease .In patients with renal disease , thiazides may precipitate azotemia .Cumulative effects of the drug may develop in patients with impaired renal function .", "label": "", "metadata": {}, "score": "57.625214"}
{"text": "The maximum regression coefficient was fixed to greater than 0.9 .The stability of the drug was tested against room temperature , freezing temperature , at bench top , reinjection , short - term and long - term stability of the drug ( Table S11 in Supplementary Material ) .", "label": "", "metadata": {}, "score": "57.66361"}
{"text": "The residue was reconstituted in 300 \u03bc L of reconstitution solution and 5.0 \u03bc L was injected onto a LC - MS / MS system .", "label": "", "metadata": {}, "score": "57.90346"}
{"text": "For both studied conditions , volunteers were required to remain upright for 4 h after dosing .Glucose solution was then served at 2 h and a standard lunch was served at 4 h after dosing .", "label": "", "metadata": {}, "score": "57.945854"}
{"text": "During each period , the volunteers were housed in a clinical pharmacology unit of Huclin Research Limited , Chennai , Tamil Nadu , India on the eve of the dosing day .", "label": "", "metadata": {}, "score": "57.980103"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : A simple and rapid LC - MS - MS assay was developed and validated for the quantitative determination of pitavastatin in human plasma .", "label": "", "metadata": {}, "score": "58.150276"}
{"text": "10 , supplement 2 , pp .7 - 11 , 2000 .View at Google Scholar \u00b7 View at Scopus .P. Drouin , \" Diamicron \u00ae MR once daily is effective and well tolerated in type 2 diabetes : a double - blind , randomized , multinational study , \" Journal of Diabetes and its Complications , vol .", "label": "", "metadata": {}, "score": "58.303772"}
{"text": "Finally extragranular ingredients were blended through a conta blender ( 30/60/120 L capacity ) for 20 min .with a speed of the motor is 15 rpm [ 22 , 23 ] .", "label": "", "metadata": {}, "score": "58.450138"}
{"text": "Am J Cardiol .2008;102(10 Suppl):1K-34K. doi pubmed .Filippatos TD , Elisaf MS .Fenofibrate plus simvastatin ( fixed - dose combination ) for the treatment of dyslipidaemia .", "label": "", "metadata": {}, "score": "58.51294"}
{"text": "in the acceptation criteria , indicating the bioequivalence of the test product , Glycon MR , and the reference product , Diamicron MR .The products can be interchangeable and administered without regard to meals .", "label": "", "metadata": {}, "score": "58.648384"}
{"text": "Complication of cardiovascular ATP - sensitive potassium channel interaction generally found in diabetes patients has not been observed at therapeutic concentrations with gliclazide MR treatment and antioxidant properties of the drug are independent of the glycemic control [ 8 ] .", "label": "", "metadata": {}, "score": "58.6868"}
{"text": "In Vitro Assay .20 tablets were grinded using a mortar and pestle and the mixture equivalent to 10 mg drug was weighted .Mixture was then transferred to 100 mL volumetric flask and dissolved with small quantity of water followed by 10 min settling . 10 mL of the solution was diluted further to 100 mL in a 100 mL volumetric flask .", "label": "", "metadata": {}, "score": "58.71386"}
{"text": "Thiazides cross the placental barrier and appear in cord blood .There is a risk of fetal or neonatal jaundice , thrombocytopenia , and possibly other adverse reactions that have occurred in adults .", "label": "", "metadata": {}, "score": "58.73042"}
{"text": "Mohiuddin SM , Pepine CJ , Kelly MT , Buttler SM , Setze CM , Sleep DJ , Stolzenbach JC .Efficacy and safety of ABT-335 ( fenofibric acid ) in combination with simvastatin in patients with mixed dyslipidemia : a phase 3 , randomized , controlled study .", "label": "", "metadata": {}, "score": "58.776245"}
{"text": "Subjects were restricted to toilet and heavy physical exercise for first 2 h following administration of the drug in order to maintain similar environment .Study schedule and sampling schedule following drug administration were followed as per protocol .", "label": "", "metadata": {}, "score": "58.850723"}
{"text": "Hydrochlorothiazide .The NTP , however , found equivocal evidence for hepatocarcinogenicity in male mice .Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed , via their diet , to doses of up to 100 and 4 mg / kg , respectively , prior to mating and throughout gestation .", "label": "", "metadata": {}, "score": "58.87806"}
{"text": "If progressive renal impairment becomes evident , consider withholding or discontinuing diuretic therapy .Thiazides have been shown to increase the urinary excretion of magnesium ; this may result in hypomagnesemia .", "label": "", "metadata": {}, "score": "58.93921"}
{"text": "Adkins JC , Faulds D. Micronised fenofibrate : a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia .Drugs . doi .", "label": "", "metadata": {}, "score": "58.951225"}
{"text": "In diabetic patients , dosage adjustments of insulin or oral hypoglycemic agents may be required .Hyperglycemia may occur with thiazide diuretics .Thus latent diabetes mellitus may become manifest during thiazide therapy .", "label": "", "metadata": {}, "score": "59.052856"}
{"text": "Keating GM , Croom KF .Fenofibrate : a review of its use in primary dyslipidaemia , the metabolic syndrome and type 2 diabetes mellitus .", "label": "", "metadata": {}, "score": "59.14955"}
{"text": "183 - 188 , 1987 .View at Google Scholar \u00b7 View at Scopus .R. E. Eckert , U. Schreier , S. Alloussi , et al . , \" Prostate selectivity of alpha1-adrenoceptor blockers , \" Journal of Urology , vol .", "label": "", "metadata": {}, "score": "59.227123"}
{"text": "Vasculitis , including Henoch - Sch\u00f6nlein purpura , has been reported with losartan .Anaphylactic reactions have been reported .Metabolic and Nutrition : Hyperkalemia , hyponatremia have been reported with losartan .", "label": "", "metadata": {}, "score": "59.24196"}
{"text": "Discussion .To develop alfuzosin 10 mg extended release tablets , active pharmaceutical ingredient ( API ) was characterized to meet the FDA regulation and showed comparative physicochemical and spectral characteristics with respect to the reference .", "label": "", "metadata": {}, "score": "59.252884"}
{"text": "Current lipid treatment guidelines emphasize the use of LDL - C : lowering therapies for cardiovascular risk reduction .Due to the overwhelming evidence generated from outcome trials , statins , which target the rate - limiting step in cholesterol biosynthesis , remain the primary method for lowering LDL - C and reducing the incidence of cardiovascular events in these patients [ 2 , 4 ] .", "label": "", "metadata": {}, "score": "59.32281"}
{"text": "METHODS : Twenty - four subjects were included in this single - dose , open - label , randomized two - way crossover study following an overnight fasting .", "label": "", "metadata": {}, "score": "59.332993"}
{"text": "The residual solvent content in the dosage forms ( in ppm ) was calculated using the equation 5 [ 27 ] as .In Vitro Dissolution Study .", "label": "", "metadata": {}, "score": "59.49085"}
{"text": "Fetal toxicity in rats , as evidenced by a slight increase in supernumerary ribs , was observed when females were treated prior to and throughout gestation with 10 mg / kg / day losartan in combination with 2.5 mg / kg / day hydrochlorothiazide .", "label": "", "metadata": {}, "score": "59.615417"}
{"text": "All subjects were monitored for vital sign , blood pressure and pulse rate to document any adverse events .Scheduled blood sample was taken from each subject in order to measure the drug in blood at each time point so that a concentration versus time graph can be constructed to describe rate and extend of absorption of the drug .", "label": "", "metadata": {}, "score": "59.7135"}
{"text": "Adverse events of gliclazide MR are mild and transient which not requiring discontinuation of the therapy .The incidence and type of adverse events are similar in the treatment with gliclazide MR or gliclazide 80 mg [ 7 ] .", "label": "", "metadata": {}, "score": "59.78956"}
{"text": "The blend for the same was carried out in 25 liter jacketed RMG involving granulation , cooling , sifting and milling followed by blending and lubrication in 1 lot .", "label": "", "metadata": {}, "score": "59.866592"}
{"text": "So it falls under major changes , and hence to get marketing approval product needs to show bioequivalent to the innovator product in therapeutic outcome .", "label": "", "metadata": {}, "score": "59.86776"}
{"text": "While 2 of these residual risk factors are modifiable by lifestyle changes , an alternative therapeutic intervention strategy is sometimes necessary to correct mixed lipid abnormalities .", "label": "", "metadata": {}, "score": "59.936165"}
{"text": "The study was assigned in both fasted and fed conditions with a single - dose , two - treatment , two - period , and two - sequence crossover study .", "label": "", "metadata": {}, "score": "59.97149"}
{"text": "In patients with more severe renal impairment , loop diuretics are preferred to thiazides , so HYZAAR is not recommended .( See DOSAGE AND ADMINISTRATION . )", "label": "", "metadata": {}, "score": "60.080654"}
{"text": "The positive ions were measured in MRM mode .The analytes were quantitated using a solid phase extraction method .Each 500 \u03bc L aliquot of standard and QC samples were mixed with 25.0 \u03bc L of deionized water . 0.2 mL of internal standard ( IS ) working solution ( 20.0 \u03bc g / mL ) was added to the entire sample collected from volunteers except blank samples .", "label": "", "metadata": {}, "score": "60.084896"}
{"text": "T. Schaefer , Melt agglomeration with polyethylene glycols in high shear mixers [ Dr Pharm .Thesis ] , The Royal Danish School of Pharmacy , Copenhagen , Denmark , 1996 . H. Leuenberger , \" New trends in the production of pharmaceutical granules : the classical batch concept and the problem of scale - up , \" European Journal of Pharmaceutics and Biopharmaceutics , vol .", "label": "", "metadata": {}, "score": "60.30571"}
{"text": "In addition , blood pressure reductions in both treatment groups were consistent between Black and non - Black patients .Given the difficulty in interpreting subset differences in large trials , it can not be known whether the observed difference is the result of chance .", "label": "", "metadata": {}, "score": "60.391533"}
{"text": "Alfuzosin is the most recently approved AARAS , with limited cardiac toxicity in the United States for symptomatic treatment of BPH .Alfuzosin , selective alpha-1a blockers [ 6 ] differs from other AARAS by the absence of a piperidine moiety and the presence of a diaminopropyl spacer , which confers alfuzosin with specific biochemical properties [ 7 ] .", "label": "", "metadata": {}, "score": "60.467514"}
{"text": "Determination of Alfuzosin in Human Plasma .A method for determining alfuzosin in human plasma was validated using an API 3000 LC / MSIMS system with detection in the range of 0.05 to 30.00 ng / mL and Aquacil C18 column ( 100 \u00d7 2.1 mm , 5 \u03bc m ) was attached for separation [ 34 , 35 ] .", "label": "", "metadata": {}, "score": "60.634468"}
{"text": "406 - 415 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . \"Uroxatral ( alfuzosin HCl extended release tablets ) , \" Detailed View : Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research ( CDER ) , May 2009 .", "label": "", "metadata": {}, "score": "60.653667"}
{"text": "The test product gave slightly higher C max in both conditions and shorter T max in the fed condition .However , there is no significant difference in pharmacokinetic characteristics between both products under fasted and fed conditions .", "label": "", "metadata": {}, "score": "60.721043"}
{"text": "The system was an isocratic run with a flow rate of 1.0 mL / min at 55 \u00b0 C using glibenclamide as an internal standard .", "label": "", "metadata": {}, "score": "60.86605"}
{"text": "Doses of 50 , 100 , and 150 mg once daily gave statistically significant systolic / diastolic mean decreases in blood pressure , compared to placebo in the range of 5.5 - 10.5/3.5 - 7.5 mmHg , with the 150 mg dose giving no greater effect than 50 - 100 mg .", "label": "", "metadata": {}, "score": "60.880722"}
{"text": "The side effects ( see WARNINGS ) of losartan are generally rare and apparently independent of dose ; those of hydrochlorothiazide are a mixture of dose - dependent ( primarily hypokalemia ) and dose - independent phenomena ( e.g. , pancreatitis ) , the former much more common than the latter .", "label": "", "metadata": {}, "score": "60.90207"}
{"text": "The significance of all primary PK parameters are to access the rate and extend of drug absorption which corresponds to onset of action ( . , rate of drug absorption ) and duration of action ( AUCT and AUCI ) that is , total amount of drug absorbed .", "label": "", "metadata": {}, "score": "60.94751"}
{"text": "The usual dose of HYZAAR is one tablet of HYZAAR 50 - 12.5 once daily .More than two tablets of HYZAAR 50 - 12.5 once daily or more than one tablet of HYZAAR 100 - 25 once daily is not recommended .", "label": "", "metadata": {}, "score": "60.98477"}
{"text": "The solution was filtered through 0.45 \u03bc m Millipore PVDF filter .The same procedure was adopted for all the samples of different locations .Procedure The absorbance of standard preparation and sample preparation was measured at 244 nm against diluents as blank ( methanol ) [ 25 , 26 ] .", "label": "", "metadata": {}, "score": "61.062492"}
{"text": "Stock solution A was prepared by mixing 30 mg methanol , 50 mg ethanol , 50 mg diethyl ether , 50 mg acetone , 50 mg isopropyl alcohol , and 50 mg ethyl acetate standard into a 100 mL volumetric flask containing 25 mL of diluents .", "label": "", "metadata": {}, "score": "61.099476"}
{"text": "During the study period , there were no reported cases of syncope in either treatment group .There were 2 ( 0.6 % ) and 0 ( 0.0 % ) cases of hypotension reported in the group treated with HYZAAR and the group treated with losartan , respectively .", "label": "", "metadata": {}, "score": "61.13556"}
{"text": "413 - 420 , 1995 .View at Google Scholar \u00b7 View at Scopus . E. G. K. Murthy , P. Sravanthi , and K. Sujana Priyadarshini , \" Studies on influence of formulation variables on performance of alfuzosin HCl extended release tablets , \" Invent .", "label": "", "metadata": {}, "score": "61.296345"}
{"text": "In addition , semilog graph was constructed to show the parametric distribution of alfuzosin content in blood plasma and population therapeutic effects ( Table 8 ) .", "label": "", "metadata": {}, "score": "61.30107"}
{"text": "View at Google Scholar \u00b7 View at Scopus .C. G. Roehrborn and R. L. Siegel , \" Safety and efficacy of doxazosin in benign prostatic hyperplasia : a pooled analysis of three double - blind , placebo - controlled studies , \" Urology , vol .", "label": "", "metadata": {}, "score": "61.32646"}
{"text": "In patients with more severe renal impairment , loop diuretics are preferred to thiazides , so HYZAAR is not recommended .Patients with Hepatic Impairment : HYZAAR is not recommended for titration in patients with hepatic impairment ( see WARNINGS , Impaired Hepatic Function ) because the appropriate 25 mg starting dose of losartan can not be given .", "label": "", "metadata": {}, "score": "61.347202"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : An automated method ( XLC - MS / MS ) that uses online solid - phase extraction coupled with HPLC - tandem mass spectrometry was reported here for the first time to quantify amlodipine in human plasma .", "label": "", "metadata": {}, "score": "61.38729"}
{"text": "l 4 , pp .233 - 238 , 1999 .View at Google Scholar .F. Lefevre - Borg , S. E. O'Connor , H. Schoemaker et al . , \" Alfuzosin , a selective \u03b1 1-adrenoceptor antagonist in the lower urinary tract , \" British Journal of Pharmacology , vol .", "label": "", "metadata": {}, "score": "61.58695"}
{"text": "doi pubmed .Saurav A , Kaushik M , Mohiuddin SM .Fenofibric acid for hyperlipidemia .Expert Opin Pharmacother . doi pubmed .Baigent C , Keech A , Kearney PM , Blackwell L , Buck G , Pollicino C , Kirby A , et al .", "label": "", "metadata": {}, "score": "61.687893"}
{"text": "Composite impurity solution was prepared by mixing 1 mL of each impurity solution to 100 mL standard solution containing 20 mg Alfuzosin hydrochloride ( AFH ) .", "label": "", "metadata": {}, "score": "61.735683"}
{"text": "Female subjects who are pregnant , breast feeding , or likely to be come pregnant during the study .Female subjects of child bearing potential must either abstain from sexual intercourse or use a reliable barrier method ( eg condom , IUD ) of contraception during the course of the study ( first dosing until the last blood collection ) .", "label": "", "metadata": {}, "score": "61.74115"}
{"text": "Volunteers .Eighteen healthy Thai male volunteers , aged between 18 - 42 years old and the body mass index within 19 - 25 kg / m 2 , were participated in the study .", "label": "", "metadata": {}, "score": "61.81839"}
{"text": "The list of other ingredients used in the development of the formulation is given in Table 1 .Various pilot batches were trialed to optimize drug release , hardness and friability ( Table 2 ) , and the optimized formula ( F025 ) was chosen based on in vitro dissolution study which corresponds to the reference dissolution among pilot formulations .", "label": "", "metadata": {}, "score": "61.893707"}
{"text": "The buffer solution was prepared after mixing 5 mL of 70 % perchloric acid with 1000 mL deionized water and finally pH was adjusted to .", "label": "", "metadata": {}, "score": "61.91912"}
{"text": "After 4 weeks of therapy , the mean SiDBP was 3.1 mmHg lower and the mean SiSBP was 5.6 mmHg lower in the group treated with HYZAAR .", "label": "", "metadata": {}, "score": "61.944794"}
{"text": "The drug is highly bound to albumin ( 95 % ) and extensively metabolized in the liver to at least 7 metabolites which show no hypoglycemic activity [ 2 ] .", "label": "", "metadata": {}, "score": "61.94821"}
{"text": "Subject has a history of allergic responses to the class of drug being tested .Subject has donated any blood and/ or plasma within the last thirty ( 30 ) days prior to the first dosing of the study .", "label": "", "metadata": {}, "score": "62.012535"}
{"text": "4 , no .4 , pp .496 - 501 , 2007 .View at Google Scholar \u00b7 View at Scopus .M. Ganesh , S. Uppatyay , R. Tivari et al . , \" Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP - HPLC , \" Pakistan Journal of Pharmaceutical Sciences , vol .", "label": "", "metadata": {}, "score": "62.053673"}
{"text": "Furthermore , molecular weight of both test and reference was 390 ( Tables S12-S15 ) from MASS spectrum for test and reference .Similar single pure peak at 339.33 \u00b0 C was obtained from the DSC of test and reference drug .", "label": "", "metadata": {}, "score": "62.1118"}
{"text": "There were no clinically significant changes in vital signs , clinical laboratory variables , ECG , X - ray and general physical examination for fasting study .", "label": "", "metadata": {}, "score": "62.11434"}
{"text": "Lithium : As with other drugs which affect the excretion of sodium , lithium excretion may be reduced .Therefore , serum lithium levels should be monitored carefully if lithium salts are to be co - administered with angiotensin II receptor antagonists .", "label": "", "metadata": {}, "score": "62.319"}
{"text": "The drug was extracted from the plasma by solid phase extraction using a 50- \u03bc m C18-E extraction column ( Strata , Phenomenex , US . )", "label": "", "metadata": {}, "score": "62.368664"}
{"text": "The renin - aldosterone link is mediated by angiotensin II , so coadministration of an angiotensin II receptor antagonist tends to reverse the potassium loss associated with these diuretics .", "label": "", "metadata": {}, "score": "62.596375"}
{"text": "Not Provided .Study Type ICMJE .Interventional .Study Phase .Phase 3 .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Double - Blind Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "62.706383"}
{"text": "Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism .Marked hypercalcemia may be evidence of hidden hyperparathyroidism .", "label": "", "metadata": {}, "score": "62.880642"}
{"text": "Blood samples were collected for 72 h after drug administration .Drug plasma concentrations were determined by HPLC with a UV detector .Analysis of pharmacokinetic characteristics was based on a non - compartmental model .", "label": "", "metadata": {}, "score": "63.027412"}
{"text": "Sample pretreatment was performed by protein precipitation and elimination using methanol followed by water dilution .Then , the mixture was passed onto the HySphere C8 EC - SE online solid - phase extraction cartridge followed by the separation of the analytes on an Agilent Eclipse XDB column .", "label": "", "metadata": {}, "score": "63.08967"}
{"text": "Forty six healthy male Indian volunteers aged between 18 and 45 years with BMI ( body mass index ) within 19 to 29.4 kg / m 2 enrolled for the study after health clearance by general physical examination and clinical lab evaluation ( including ECG and chest X - ray ) .", "label": "", "metadata": {}, "score": "63.09881"}
{"text": "Figure 2 depicts mean plasma concentration versus time profiles under the fed condition and the corresponding pharmacokinetic characteristics are summarized in Table 4 .The profile of the test product showed slightly higher .", "label": "", "metadata": {}, "score": "63.131306"}
{"text": "Selective alpha - adrenergic receptor antagonists ( AARAs ) such as prazosin , terazosin , doxazosin , and tamsulosin are important in the treatment of symptomatic Benign prostatic hyperplasia ( BPH )", "label": "", "metadata": {}, "score": "63.190056"}
{"text": "HYZAAR 50 - 12.5 , HYZAAR 100 - 12.5 , and HYZAAR 100 - 25 may also contain carnauba wax .MK-0954E Phase III Long - Term Study in Participants With Hypertension ( MK-0954E-356 ) .", "label": "", "metadata": {}, "score": "63.40434"}
{"text": "The peak of the corresponding impurities was identified [ 29 ] .The area of the peak for each impurity was calculated and finally estimated the % of known impurity present in the formulation by the formula 4 .", "label": "", "metadata": {}, "score": "63.46564"}
{"text": "601 - 610 , 1990 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Guinebault , M. Broquaire , C. Colafranceschi , and J. P. Thenot , \" High - performance liquid chromatographic determination of alfuzosin in biological fluids with fluorimetric detection and large - volume injection , \" Journal of Chromatography , vol .", "label": "", "metadata": {}, "score": "63.49555"}
{"text": "After being eluted from the cartridge , the analyte and the internal standard were separated by HPLC and detected by tandem mass spectrometry .Mass spectrometric detection was achieved in the multiple reaction monitoring mode using a quadrupole tandem mass spectrometer in the positive electrospray ionization mode .", "label": "", "metadata": {}, "score": "63.60618"}
{"text": "Hydrochlorothiazide is a thiazide diuretic .Thiazides affect the renal tubular mechanisms of electrolyte reabsorption , directly increasing excretion of sodium and chloride in approximately equivalent amounts .", "label": "", "metadata": {}, "score": "63.651806"}
{"text": "The slope of the terminal log - linear portion of the plasma concentration - time profile was determined by least - square regression to find an elimination rate constant ( . ) referred to the ratio of the mean value of the pharmacokinetic parameter of the test product to the reference product .", "label": "", "metadata": {}, "score": "63.653847"}
{"text": "341 - 348 , 1994 ( French ) .View at Google Scholar .P. E. Jennings , \" From hemobiology to vascular disease : a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease , \" Journal of Diabetes and its Complications , vol . 8 , no .", "label": "", "metadata": {}, "score": "63.65429"}
{"text": "Since assay results of formulations and impurities were found within the acceptance criteria , the HPLC method was precise for quantification of impurities in alfuzosin hydrochloride API .", "label": "", "metadata": {}, "score": "63.66737"}
{"text": "6934 , pp .929 - 930 , 1994 .View at Google Scholar \u00b7 View at Scopus .W. J. G. Hellstrom , R. A. Schmidt , T. F. Lue , and E. A. Tanagho , \" Neuromuscular dysfunction in nonbacterial prostatitis , \" Urology , vol .", "label": "", "metadata": {}, "score": "63.728767"}
{"text": "( a ) Chemical structure of fenofibrate and fenofibric acid ; ( b ) Comparison of fenofibrate formulations .Methods .Results were limited to English language , Clinical Trials , Humans , Reviews , and publication date between 1993 and 2012 , yielding 46 citations of interest .", "label": "", "metadata": {}, "score": "63.7584"}
{"text": "( See CLINICAL PHARMACOLOGY , Drug Interactions . )In humans , two inhibitors of P450 3A4 have been studied .Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .", "label": "", "metadata": {}, "score": "63.826313"}
{"text": "The overall interday precision ( % CV ) and accuracy for the standards and quality control samples were 1.4 to 6.0 % and 96.1 to 104 % , respectively .", "label": "", "metadata": {}, "score": "64.09458"}
{"text": "History of alcohol or drugs abuse or intake of alcohol within 24 hours prior to the period of confinement .Consume of inductive drugs and/or enzymatic inhibitors ( CYP450 - hepatic ) , that are toxic for the organism or presenting long half - life 's elimination within 30 days prior to study initiation .", "label": "", "metadata": {}, "score": "64.14572"}
{"text": "The physicochemical characteristics of the finished products like hardness , assay , dissolution , and friability all are in the limit of the USP ( United State Pharmacopeia standard ) .", "label": "", "metadata": {}, "score": "64.30876"}
{"text": "Full Prescribing Information , Gate Pharmaceuticals , Sellersville , PA , 2003 .Triglide \u00ae ( fenofibrate ) .Full Prescribing Information , Sciele Pharma , Atlanta , GA , 2007 .", "label": "", "metadata": {}, "score": "64.34952"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Enoxaparin is a low - molecular - weight heparin ( LMWH ) indicated for antithrombosis .", "label": "", "metadata": {}, "score": "64.38188"}
{"text": "In the present model sequence effects were tested at 10 % level of significance whereas other effects were tested at 5 % level of significance .", "label": "", "metadata": {}, "score": "64.39965"}
{"text": "Hydrochlorothiazide is a white , or practically white , crystalline powder with a molecular weight of 297.74 , which is slightly soluble in water , but freely soluble in sodium hydroxide solution .", "label": "", "metadata": {}, "score": "64.427414"}
{"text": "Fenofibrate ( Fig .1a , left ) , a pro - drug , is pharmacologically inactive and undergoes rapid hydrolysis at the ester bond to form the active metabolite fenofibric acid ( Fig .", "label": "", "metadata": {}, "score": "64.45531"}
{"text": "The 2 formulations were to be considered bioequivalent if the 90 % CIs for the logarithm - transformed values of C(max ) , T(max ) , AUC(0-t ) , and AUC(0-infinity ) fell within the predetermined range of 80 % to 125 % .", "label": "", "metadata": {}, "score": "64.534424"}
{"text": "Toth PP , Potter D , Ming EE .Prevalence of lipid abnormalities in the United States : the National Health and Nutrition Examination Survey 2003 - 2006 .", "label": "", "metadata": {}, "score": "64.54689"}
{"text": "35 out of 42 subjects completed both the periods of the fasting study and there were 7 discontinued subjects .2 subjects were prematurely withdrew their consent without any reason , 3 subject discontinued due to severe headache and other two subjects did not report for the second period to the facility .", "label": "", "metadata": {}, "score": "64.590744"}
{"text": "November 2011 ( final data collection date for primary outcome measure ) .Eligibility Criteria ICMJE .Participant is being treated with a single , or dual combination treatment for hypertension and will be able to discontinue the prior antihypertensive medication .", "label": "", "metadata": {}, "score": "64.59732"}
{"text": "An integrator was used to determine the chromatographic peak heights of alfuzosin and internal standard .The peak height ratios of alfuzosin to internal standard were used for the calculation of unknown concentrations .", "label": "", "metadata": {}, "score": "64.7564"}
{"text": "Introduction .The chronic prostatitis syndromes and symptomatic benign prostatic hyperplasia ( BPH ) are common among aged men and women [ 1 ] .The etiology of prostatitis syndrome remain elusive , it does appear to be associated with a high incidence of voiding dysfunction [ 2 ] .", "label": "", "metadata": {}, "score": "64.76337"}
{"text": "Plasma harvested from blood was analyzed for ibuprofen by a sensitive and validated high - performance liquid chromatographic assay .The maximum plasma concentration ( Cmax ) , area under the plasma concentration - curve up to the last measurable concentration ( AUC0-t ) , and to infinity ( AUC0-infinity ) were analyzed statistically under the assumption of a multiplicative model .", "label": "", "metadata": {}, "score": "64.83089"}
{"text": "One patient discontinued taking HYZAAR due to a minor increase in serum creatinine .Hemoglobin and Hematocrit : Small decreases in hemoglobin and hematocrit ( mean decreases of approximately 0.14 grams percent and 0.72 volume percent , respectively ) occurred frequently in patients treated with HYZAAR alone , but were rarely of clinical importance .", "label": "", "metadata": {}, "score": "64.96141"}
{"text": "The graph of fraction of drug dissolved in vitro versus fraction of drug absorb in vivo along with correlation coefficients at each dissolution media was separately constructed ( Figures 2(a ) - 2(c ) ) .", "label": "", "metadata": {}, "score": "64.9765"}
{"text": "Lancet . doi .Micronized - Fenofibrate ( generic ) .Full Prescribing Information , Global Pharmaceuticals , Philadelphia , PA , 2009 .Tricor \u00ae ( fenofibrate ) .", "label": "", "metadata": {}, "score": "65.00097"}
{"text": "For information on the specific adverse events observed during the study period , see ADVERSE REACTIONS , Severe Hypertension .WARNINGS .Fetal / Neonatal Morbidity and Mortality .", "label": "", "metadata": {}, "score": "65.0143"}
{"text": "The data was acquired by and calculated on Applied Biosystems \" Analyst \" version 1.4.1 Software .Linear regression , with l / x 2 weighting , was used to obtain the best fit of the data for the calibration curves ( figure not shown ) .", "label": "", "metadata": {}, "score": "65.0833"}
{"text": "The proton NMR spectra between test and reference showed prominent peak at 11.9 ppm , 8.89 ppm , 7.7 ppm , and 3.34 ppm indicating similar chemical environment which was further confirmed by 13C NMR .", "label": "", "metadata": {}, "score": "65.08391"}
{"text": "HYZAAR 50 - 12.5 contains 4.24 mg ( 0.108 mEq ) of potassium , HYZAAR 100 - 12.5 contains 8.48 mg ( 0.216 mEq ) of potassium , and HYZAAR 100 - 25 contains 8.48 mg ( 0.216 mEq ) of potassium .", "label": "", "metadata": {}, "score": "65.235504"}
{"text": "Healthy Chinese male volunteers were eligible for this single - dose , randomized - sequence , open - label , 2-period crossover study .", "label": "", "metadata": {}, "score": "65.36168"}
{"text": "The mean recovery of impurities A , B , D , and E ( mean \u00b1 RSD ) were .Bioanalytical Method Validation Report in Human Plasma .", "label": "", "metadata": {}, "score": "65.42815"}
{"text": "The significant correlation between in vitro and in vivo parameters indicated that the IVIVC was excellent in predicting AUCT , but not acceptable in predicting .", "label": "", "metadata": {}, "score": "65.43517"}
{"text": "Effects of fibrates on cardiovascular outcomes : a systematic review and meta - analysis .Lancet . doi .Bruckert E , Labreuche J , Deplanque D , Touboul PJ , Amarenco P. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "65.51776"}
{"text": "279 - 288 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Leuenberger , M. Usteri , G. Imanidis , and S. Winzap , \" Monitoring the granulation process : granulate growth , fractal dimensionality and percolation threshold , \" Bollettino Chimico Farmaceutico , vol .", "label": "", "metadata": {}, "score": "65.818146"}
{"text": "Results and Discussion .Volunteer Demography and Safety .Eighteen healthy Thai male volunteers participated in the study .Their mean values of age , weight , height , and body mass index were 28.61 \u00b1 6.63 yr , 64.23 \u00b1 5.00 kg , 1.69 \u00b1 0.04 m , and 22.38 \u00b1 1.65 kg / m 2 , respectively .", "label": "", "metadata": {}, "score": "65.84401"}
{"text": "Group no . 1 was administered with the test product , following by the reference product whereas Group no . 2 started with the reference product , following by the test product .", "label": "", "metadata": {}, "score": "65.89177"}
{"text": "listed in Table 3 are within the acceptance criteria , indicating that the two products were bioequivalent under the fed condition .Effect of Food .", "label": "", "metadata": {}, "score": "66.02944"}
{"text": "Stock solutions A and B were mixed in a ratio of 5 : 1 ( v / v ) in diluents for combined standard .In brief , the working procedure is as follows .", "label": "", "metadata": {}, "score": "66.13518"}
{"text": "153 - 160 , 2006 .View at Google Scholar .Center for Drug Evaluation and Research ( CDER ) , Guidance for Industry , Food - Effect Bioavailability and Fed Bioequivalence Studies , US FDA , 2002 .", "label": "", "metadata": {}, "score": "66.25276"}
{"text": "When administered concurrently , the following drugs may interact with thiazide diuretics : .Alcohol , barbiturates , or narcotics - potentiation of orthostatic hypotension may occur .", "label": "", "metadata": {}, "score": "66.66646"}
{"text": "Peak ( 6 hour ) effects were uniformly , but moderately larger than trough effects , with the trough to peak ratio for systolic and diastolic responses 50 - 95 % and 60 - 90 % , respectively .", "label": "", "metadata": {}, "score": "66.710335"}
{"text": "Its empirical formula is C 22 H 22 ClKN 6 O , and its structural formula is : .Losartan potassium is a white to off - white free - flowing crystalline powder with a molecular weight of 461.01 .", "label": "", "metadata": {}, "score": "66.79816"}
{"text": "American Pharmaceutical Association ( 2003 ) has approved drug therapeutic equivalence information ( 2003 ) .Hence pharmacokinetics evaluation is critical to establish therapeutic equivalence in turn establish bioequivalence .", "label": "", "metadata": {}, "score": "66.82609"}
{"text": "Additionally based upon the design of experiments on laboratory scale batches , acceptable ranges for critical process parameters for melting , mixing , and compression were determined .", "label": "", "metadata": {}, "score": "66.86485"}
{"text": "Collected blood samples were centrifuged at 3500 rpm for 10 minutes at temperature 10 \u00b0 C to collect plasma .Plasma samples were kept in RIA vial for bioanalysis .", "label": "", "metadata": {}, "score": "66.88746"}
{"text": "Based on NHANES data from 2003 to 2006 , it is estimated that 21 % of US adults have mixed dyslipidemia , with nearly 6 % having all 3 lipid abnormalities [ 3 ] .", "label": "", "metadata": {}, "score": "66.91342"}
{"text": "Sacks FM , Carey VJ , Fruchart JC .Combination lipid therapy in type 2 diabetes .N Engl J Med . 2010;363(7):692 - 694 ; author reply 694 - 695 . doi .", "label": "", "metadata": {}, "score": "67.07202"}
{"text": "However , fenofibrate is a neutral , lipophilic compound that is practically insoluble in water , making it challenging to consistently achieve therapeutic levels [ 17 ] .", "label": "", "metadata": {}, "score": "67.27451"}
{"text": "Fed Condition Each volunteer randomly received a 30-mg gliclazide MR tablet , either the test product or the reference product , at 10 min after receiving a Melander type standard breakfast as recommended in the earlier study [ 9 ] .", "label": "", "metadata": {}, "score": "67.31482"}
{"text": "After oral administration of hydrochlorothiazide , diuresis begins within 2 hours , peaks in about 4 hours and lasts about 6 to 12 hours .Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney .", "label": "", "metadata": {}, "score": "67.3348"}
{"text": "Full Prescribing Information , Abbott Laboratories , Chicago , IL , 2004 .Antara \u00ae ( fenofibrate ) .Full Prescribing Information , Oscient Pharmaceuticals Corporation , Emeryville , CA , 2006 .", "label": "", "metadata": {}, "score": "67.52877"}
{"text": "Alfuzosin hydrochloride and lactose monohydrate were passed through no .40 mesh ; mono- and diglycerides was sifted through no .20 mesh and blended together in jacketed Rapid Mixer Granulator ( RMG ) for 10.0 min with intermittent raking of the mixture .", "label": "", "metadata": {}, "score": "67.563995"}
{"text": "Reference formulation .Detailed Description : .This study is prospective , open - label , randomized , crossover , single dose , with 02 treatments , 02 sequences and 02 periods .", "label": "", "metadata": {}, "score": "67.594376"}
{"text": "Interventional .Study Phase .Not Provided .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Bio - equivalence Study Intervention Model : Crossover Assignment Masking : Open Label .", "label": "", "metadata": {}, "score": "67.70482"}
{"text": "Method did not show any matrix effects since the accuracy of the method was 103 % at highest calibration concentration .The recovery of the internal standard was about 68 % ( Table 3 ) .", "label": "", "metadata": {}, "score": "67.76338"}
{"text": "Inactive ingredients are microcrystalline cellulose , lactose hydrous , pregelatinized starch , magnesium stearate , hydroxypropyl cellulose , hypromellose , and titanium dioxide .HYZAAR 50 - 12.5 and HYZAAR 100 - 25 also contain D&C yellow No . 10 aluminum lake .", "label": "", "metadata": {}, "score": "67.88581"}
{"text": "Has nanotechnology led to improved therapeutic outcomes ?Drug Dev Ind Pharm .doi pubmed .Rawat N , Kumar SM , Mahadevan N. Solubility : particle size reduction is a promising approach to improve the bioavailability of lipophillic drugs .", "label": "", "metadata": {}, "score": "68.02103"}
{"text": "Conflict of Interests .The authors had no conflict of interests and the formulation developed and used in the present study has no commercial value since it has not been marketed and will not be marketed in future .", "label": "", "metadata": {}, "score": "68.095184"}
{"text": "Measurement is obtained directly from the plasma concentration curve of the drug ( non - compartmental method ) .Measurement of AUC0-inf is obtained directly from the plasma concentration curve of drug against time ( non - compartmental method ) .", "label": "", "metadata": {}, "score": "68.281975"}
{"text": "The standard curve concentrations range from 0.050 to 30.0 ng / mL. On each day of validation , five sets of QC samples at 0.1500 ng / mL ( low ) , 2.000 ng / mL ( medium ) , and 25.00 ng / mL ( high ) were assayed for a total of twelve sets of QC samples for all six days .", "label": "", "metadata": {}, "score": "68.29838"}
{"text": "The dissolution media was 500 mL of 0.1 N HCl , for comparing the release rate among the trial lab scaled batches and to establish the reproducibility of the release rate from the formulation .", "label": "", "metadata": {}, "score": "68.404526"}
{"text": "Nanoparticle formulations further reduced particle size , leading to a significantly increased ratio of surface area to volume and greater bioavailability ( Fig .1b ) [ 18 ] .", "label": "", "metadata": {}, "score": "68.47839"}
{"text": "The method and condition of the study were clearly informed to all volunteers , and the signed informed consent was obtained from all volunteers before entering the study .", "label": "", "metadata": {}, "score": "68.56581"}
{"text": "Mumbai , India .Opacode Black 8 - 1 - 8152 HV was collected from Colorcon India limited .Working standards were procured from Zydus Cadila Healthcare Ltd.", "label": "", "metadata": {}, "score": "68.65781"}
{"text": "ng , nanograms ; mL , milliliter .Cmax is defined as the maximum or \" peak \" concentration of a drug observed after its administration .", "label": "", "metadata": {}, "score": "68.670364"}
{"text": "There may be new information .This leaflet does not take the place of talking with your doctor about your condition and treatment .What is the most important information I should know about HYZAAR ?", "label": "", "metadata": {}, "score": "68.7592"}
{"text": "Finally elemental analysis of test and reference showed no change in C , H , and N contents of the drugs implied the requirement as per compendial limit .", "label": "", "metadata": {}, "score": "68.77387"}
{"text": "All patients should be cautioned that inadequate fluid intake , excessive perspiration , diarrhea , or vomiting can lead to an excessive fall in blood pressure , with the same consequences of lightheadedness and possible syncope .", "label": "", "metadata": {}, "score": "68.78435"}
{"text": "The safety profile was evaluated by recording adverse events ( AEs ) , assessed using physical examination including vital signs , spontaneous reporting , and clinical laboratory results .", "label": "", "metadata": {}, "score": "68.797585"}
{"text": "The phase extraction validation was presented by average accuracy and precision of 96.86 % and 6.27 % for a fasted unknown sample and 95.69 % and 10.39 % for a fed unknown sample , respectively .", "label": "", "metadata": {}, "score": "68.88417"}
{"text": "Lactose monohydrate NF was procured from Medreich labs , Bangalore , India .The purified talc USP ( Luzenac Corp. ) and magnesium stearate NF were purchased from Signet Chemical Corporation Pvt .", "label": "", "metadata": {}, "score": "68.888596"}
{"text": "So , statistical equivalence of . , AUCT and AUCI between test and reference drug would bring a substituted generic which can switch over innovator .", "label": "", "metadata": {}, "score": "69.07854"}
{"text": "The calibration curve ranged from 0.10 to 10.22ng / mL , and both the intra- and inter - day precision and accuracy values were within 8 % .", "label": "", "metadata": {}, "score": "69.128"}
{"text": "Liver Function Tests : Occasional elevations of liver enzymes and/or serum bilirubin have occurred .In patients with essential hypertension treated with HYZAAR alone , no patients were discontinued due to these laboratory adverse experiences .", "label": "", "metadata": {}, "score": "69.632416"}
{"text": "The time of maximum observed concentration ( Tmax ) is obtained directly from the plasma concentration curve of the drug by non - compartimental method .", "label": "", "metadata": {}, "score": "69.63813"}
{"text": "The lower limit of quantitation was 10.0 ng / mL with the accuracy ( % ) and precision ( CV % ) of 114.26 and 14.99 , respectively .", "label": "", "metadata": {}, "score": "69.66502"}
{"text": "In addition , there was no evidence of direct genotoxicity in the in vitro alkaline elution assay in rat hepatocytes and in vitro chromosomal aberration assay in Chinese hamster ovary cells at noncytotoxic concentrations .", "label": "", "metadata": {}, "score": "69.713745"}
{"text": "from the fasted and fed conditions using ANOVA .The magnitude of the difference between fasted and fed conditions was calculated as 90 % CI of the ratio ( fed / fasted ) using the residual variance of the three - way ANOVA with the reference as the fasted condition .", "label": "", "metadata": {}, "score": "69.75678"}
{"text": "Executive Summary of The Third Report of The National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , And Treatment of High Blood Cholesterol In Adults ( Adult Treatment Panel III ) .", "label": "", "metadata": {}, "score": "69.82706"}
{"text": "It is solely formulated for research purpose to establish bioequivalence of this generic formulation .References .P. Abrams , \" New words for old : lower urinary tract symptoms for ' prostatism ' , \" British Medical Journal , vol .", "label": "", "metadata": {}, "score": "70.112045"}
{"text": "Because of the potential for adverse effects on the nursing infant , a decision should be made whether to discontinue nursing or discontinue the drug , taking into account the importance of the drug to the mother .", "label": "", "metadata": {}, "score": "70.16116"}
{"text": "2011 , Article ID Inventi : ndds/106/11 , 2011 .View at Google Scholar .J. M. Newton , S. Boutel , and J. Chatchawalsaisin , \" Preparation of spherical granules by extrusion / spheronization without microcrystalline cellulose , \" in Proceedings of the 7th International Symposium on Agglomeration , pp .", "label": "", "metadata": {}, "score": "70.33148"}
{"text": "Volunteers with psychiatric or psychological illness unless they are considered clinically irrelevant by the investigator .History or presence of hepatic , renal or gastrointestinal illness or other condition that interferes on drug 's absorption , distribution , excretion or metabolism .", "label": "", "metadata": {}, "score": "70.39198"}
{"text": "Lithium - should not generally be given with diuretics .Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .", "label": "", "metadata": {}, "score": "70.4055"}
{"text": "The calibration curve ranged from 5.25 to 525 ng / mL. Meanwhile both the intra - day and inter - day precision values ( relative standard deviation ) were within 4.45 % .", "label": "", "metadata": {}, "score": "70.52579"}
{"text": "These patients should be asked to report pregnancies to their physicians as soon as possible .Symptomatic Hypotension : A patient receiving HYZAAR should be cautioned that lightheadedness can occur , especially during the first days of therapy , and that it should be reported to the prescribing physician .", "label": "", "metadata": {}, "score": "70.61984"}
{"text": "Alfuzosin , a selective alpha-1a antagonistis is the most recently approved AARAS , with limited cardiac toxicity and exclusively used for lower urinary tract syndromes ( LUTS ) .", "label": "", "metadata": {}, "score": "70.709274"}
{"text": "Cardiovasc Drugs Ther . doi pubmed .Kipnes MS , Roth EM , Rhyne JM , Setze CM , Lele A , Kelly MT , Sleep DJ , et al .", "label": "", "metadata": {}, "score": "70.71181"}
{"text": "Tell your doctor if you get any side effect that bothers you or that wo n't go away .This is not a complete list of side effects .", "label": "", "metadata": {}, "score": "70.806694"}
{"text": "5 , no . 2 , pp .59 - 68 , 2009 .View at Google Scholar .J. W. Moore and H. H. Flanner , \" Mathematical comparison of dissolution profiles , \" Pharmaceutical Technology , vol .", "label": "", "metadata": {}, "score": "70.97789"}
{"text": "High blood pressure is the most common cause of LVH .What are the possible side effects of HYZAAR ? allergic reaction .Symptoms of an allergic reaction are swelling of the face , lips , throat or tongue .", "label": "", "metadata": {}, "score": "71.14342"}
{"text": "Publication date & source : 2010 , Arzneimittelforschung ., 60(12):749 - 53 .Publication type : Comparative Study ; Randomized Controlled Trial ; Research Support , Non - U.S. Gov't .", "label": "", "metadata": {}, "score": "71.17093"}
{"text": "46 , no . 1 , pp .92 - 125 , 1993 .View at Google Scholar \u00b7 View at Scopus . K. G. Alberti , \" Gliclazide : review of metabolic and vascular action , \" Diab\u00e8te & M\u00e9tabolisme , vol .", "label": "", "metadata": {}, "score": "71.22351"}
{"text": "This work was supported by Pharma Nueva Co. , Ltd , Thailand .All authors do not have a direct financial relation with the commercial identities mentioned in the paper .", "label": "", "metadata": {}, "score": "71.31355"}
{"text": "lower the chance of stroke in patients with high blood pressure and a heart problem called left ventricular hypertrophy ( LVH ) .HYZAAR may not help Black patients with this problem .", "label": "", "metadata": {}, "score": "71.35383"}
{"text": "Clin Drug Investig .doi pubmed .Rosenson RS , Carlson DM , Kelly MT , Setze CM , Hirshberg B , Stolzenbach JC , Williams LA .", "label": "", "metadata": {}, "score": "71.43163"}
{"text": "Hence the cross over design requires minimum subjects to establish bioequivalence of the generic drug .The bias of selecting the subjects in the equivalence trial was further removed by using randomization schedule ( data not shown ) .", "label": "", "metadata": {}, "score": "71.43845"}
{"text": "Gender .Both .Ages .18 Years and older .Accepts Healthy Volunteers .Yes .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects This study is prospective , open - label , randomized , crossover , single dose , with 02 treatments , 02 sequences and 02 periods .", "label": "", "metadata": {}, "score": "71.4936"}
{"text": "Statistic Analysis for Bioequivalence .and AUC was performed on the logarithmically ( Ln ) transformed data .The 90 % confidence interval ( CI ) for the ratio of the test product to the reference product based on Ln - transformed data was interpreted .", "label": "", "metadata": {}, "score": "71.63571"}
{"text": "60 , pp .61638 - 61643 , 1995 .R. W. Johnstone and M. W. Thring , Pilot Plants , Models and Scale - Up Methods in Chemical Engineering , McGraw - Hill , New York , NY , USA , 1957 .", "label": "", "metadata": {}, "score": "71.88458"}
{"text": "The profiles of the reference product in both conditions were comparable whereas the profile of the test product under the fed condition gave the faster .", "label": "", "metadata": {}, "score": "71.935135"}
{"text": "Among these AARAS only tamsulosin is uroselective which selectively blocked alpha-1a receptor ( alpha-1a predominate in the urinary tract and 1b in the vasculature ) .", "label": "", "metadata": {}, "score": "72.016685"}
{"text": "All the subjects were restricted to 2 h after drug administration of water intake and toileting , while at other time water was given ad libitum .", "label": "", "metadata": {}, "score": "72.15086"}
{"text": "Unit impulse response of in vivo data followed by deconvolution of the data was used to build correlation with in vitro dissolution data [ 36 ] .", "label": "", "metadata": {}, "score": "72.23491"}
{"text": "Gliclazide is a second - generation sulfonylurea , an oral hypoglycemic agent used in the treatment of noninsulin dependent diabetes mellitus .It decreases blood glucose level by stimulating insulin secretion from pancreatic \u03b2 -cells and increasing sensitivity of the \u03b2 -cells to a glucose stimulus [ 1 ] .", "label": "", "metadata": {}, "score": "72.417206"}
{"text": "Participant is pregnant or breastfeeding , or expecting to conceive OR the pregnancy test is positive at screening visit ( Visit 1 ) .Participant is currently participating or has participated in a study with an investigational compound or device within 30 days of signing informed consent .", "label": "", "metadata": {}, "score": "72.58324"}
{"text": "The observed hardness ( mean \u00b1 SD kp , .( Table S4 in Supplementary Material ) .The friability of the all batches was found to be less than 1 % ( 0.8 % for biobatch and 0.84 % for commercial production batch ) ( Table S4 in Supplementary Material ) .", "label": "", "metadata": {}, "score": "72.6892"}
{"text": "Circulation . doi pubmed .Fernandez G , Spatz ES , Jablecki C , Phillips PS .Statin myopathy : a common dilemma not reflected in clinical trials .", "label": "", "metadata": {}, "score": "72.68957"}
{"text": "In the past , the treatment of LUTS , associated with clinical BPH , was restricted to surgical interventions , such as transurethral resection of the prostate or open nucleation of the enlarged adenoma [ 4 ] .", "label": "", "metadata": {}, "score": "72.77348"}
{"text": "Supelco Capillary column ( .mm , 3 \u03bc m ) was used at nitrogen carrier gas flow rate of 2.0 psi .The initial column temperature was kept for 35 \u00b0 C and increased 25 \u00b0 C / minute thereafter to reach the final column temperature of 225 \u00b0 C while the injection port temperature and detector temperature were kept 230 \u00b0 C and 250 \u00b0 C , respectively .", "label": "", "metadata": {}, "score": "72.77983"}
{"text": "AUC0-t is calculated from time 0 ( prior to administration of medication ) to time t ( the time of the last quantifiable concentration ) .", "label": "", "metadata": {}, "score": "73.07508"}
{"text": "Although any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances ( as in liver disease or renal disease ) , chloride replacement may be required in the treatment of metabolic alkalosis .", "label": "", "metadata": {}, "score": "73.29027"}
{"text": "All values were within the predetermined bioequivalence range .Seven AEs were reported somnolence ( 4 subjects [ 9.1 % ] ) and dizziness ( 3 subjects [ 6.8 % ] ) .", "label": "", "metadata": {}, "score": "73.63516"}
{"text": "J Am Coll Cardiol .2009;53(suppl A):A208 .Roth EM , Rosenson RS , Carlson DM , Fukumoto SM , Setze CM , Blasetto JW , Khurmi NS , et al .", "label": "", "metadata": {}, "score": "73.96989"}
{"text": "Contraction stress testing ( CST ) , a non - stress test ( NST ) , or biophysical profiling ( BPP ) may be appropriate , depending upon the week of pregnancy .", "label": "", "metadata": {}, "score": "74.11819"}
{"text": "The molten mass was cooled at room temperature by passing cold water through jacket and the dried granules were sifted with colloidal silicon dioxide through 1.2 mm screen .", "label": "", "metadata": {}, "score": "74.50804"}
{"text": "Medical writing support was provided by Nicole Gudleski , PhD , of Complete Publication Solutions , LLC , to the authors in the development of the publication .", "label": "", "metadata": {}, "score": "74.620766"}
{"text": "Study .IVIV link model was used to build correlation ; in vitro fraction of drug released at each time points was subjected to Weibul model fit options in IVIVC tool kit of WinNonlin v 5.3 .", "label": "", "metadata": {}, "score": "74.69122"}
{"text": "Log transformation was done to bring the nonparametric data to parametric forms so that two one sided test and ANOVA can able to estimate the ratio and 90 % confidence interval .", "label": "", "metadata": {}, "score": "74.84561"}
{"text": "The function of this parameter is to provide information about what percentage of the theoretical curve ( AUC0-inf ) was possible to determine experimentally ( AUC0-t )", "label": "", "metadata": {}, "score": "75.14235"}
{"text": "Staels B , Dallongeville J , Auwerx J , Schoonjans K , Leitersdorf E , Fruchart JC .Mechanism of action of fibrates on lipid and lipoprotein metabolism .", "label": "", "metadata": {}, "score": "75.34325"}
{"text": "Angiotensin II [ formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme ( ACE , kininase II ) ] , is a potent vasoconstrictor , the primary vasoactive hormone of the renin - angiotensin system and an important component in the pathophysiology of hypertension .", "label": "", "metadata": {}, "score": "75.50533"}
{"text": "At baseline , 1195 ( 13 % ) had diabetes , 1326 ( 14 % ) had isolated systolic hypertension , 1469 ( 16 % ) had coronary heart disease , and 728 ( 8 % ) had cerebrovascular disease .", "label": "", "metadata": {}, "score": "75.53845"}
{"text": "UV absorption spectrum of sample preparation exhibited maxima and minima , which were at the same wavelengths as that of standard preparation obtained in the assay .", "label": "", "metadata": {}, "score": "75.62191"}
{"text": "6 , pp .621 - 625 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .United States Pharmacopoeia , 27 , National Formulary 22 , USP Convention , Rockville 2004 .", "label": "", "metadata": {}, "score": "75.81545"}
{"text": "References .Rosamond W , Flegal K , Furie K , Go A , Greenlund K , Haase N , Hailpern SM , et al .", "label": "", "metadata": {}, "score": "75.84143"}
{"text": "Davidson MH , Maki KC , Pearson TA , Pasternak RC , Deedwania PC , McKenney JM , Fonarow GC , et al .Results of the National Cholesterol Education ( NCEP ) Program Evaluation ProjecT Utilizing Novel E - Technology ( NEPTUNE ) II survey and implications for treatment under the recent NCEP Writing Group recommendations .", "label": "", "metadata": {}, "score": "76.07254"}
{"text": "Separation was achieved on a Zorbax SB - Aq ( 4.6 \u00d7 250 mm , 5 \u03bc m ) column under isocratic conditions .The accuracy was higher than 90.92 % , while the intra- and interday precision were less than 6.26 % .", "label": "", "metadata": {}, "score": "77.057205"}
{"text": "The blood pressure and heart rate were monitored using Digital Blood Pressure Monitor ( model UA-767 Plus , A&D Medical , Tokyo , Japan ) .", "label": "", "metadata": {}, "score": "77.58264"}
{"text": "Each cartridge was washed with 1.0 mL of deionized water by centrifugation for 2 min at 3000 rpm .The sample was eluted from Oasis cartridge by adding 1.0 mL of methanol and centrifugation for 2 min at 3000 rpm .", "label": "", "metadata": {}, "score": "77.61357"}
{"text": "Determination method was modified from the assay validation employed by Noguchi et al .[14 ] .Chromatographic system consisted of a 5- \u03bc m C-18 reversed phase column equipped with a guard column of the same material ( Inertsil ODS-3 , GL Sciences , Japan ) and the UV detector set at 230 nm .", "label": "", "metadata": {}, "score": "77.63976"}
{"text": "The most likely manifestation of overdosage would be hypotension and tachycardia ; bradycardia could occur from parasympathetic ( vagal ) stimulation .If symptomatic hypotension should occur , supportive treatment should be instituted .", "label": "", "metadata": {}, "score": "77.85046"}
{"text": "A total of 36 healthy adult subjects were enrolled in the study .Of all the subjects 34 subjects ( 21 males and 13 females ) completed the study .", "label": "", "metadata": {}, "score": "77.89189"}
{"text": "The molten masses was then chopped with fast chopper speed and slow mixing for 2.0 min .Hot granules were cooled down for the 2 h at room temperature .", "label": "", "metadata": {}, "score": "78.037834"}
{"text": "Blood samples were collected before dosing and at 0.33 , 0.67 , 1 , 1.5 , 2 , 3 , 4 , 5 , 6 , 8 , 10 , 12 , 15 , 24 , 36 , 48 , 72 , and 96 hours after dosing .", "label": "", "metadata": {}, "score": "78.19814"}
{"text": "Cardiovasc Drugs Ther . doi pubmed .Ballantyne CM , Jones PH , Kelly MT , Setze CM , Lele A , Thakker KM , Stolzenbach JC .", "label": "", "metadata": {}, "score": "78.1987"}
{"text": "Methods and Materials .Materials .Alfuzosin hydrochloride was obtained from the Dr. Reddys Laboratory , Hyderabad , India .Marketed product was obtained from the local pharmacy shop .", "label": "", "metadata": {}, "score": "78.2652"}
{"text": "How should I store HYZAAR ?General information about HYZAAR .Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets .", "label": "", "metadata": {}, "score": "78.57355"}
{"text": "For anti - Xa activity , the 90 % CIs of C(max ) , AUC(0-t ) , and AUC(0-infinity ) were 100.4 % to 106.7 % , 100.7 % to 105.8 % , and 100.7 % to 106.1 % , respectively .", "label": "", "metadata": {}, "score": "78.8111"}
{"text": "There was no significant effect on heart rate .There was no difference in response for men and women or in patients over or under 65 years of age .", "label": "", "metadata": {}, "score": "79.260704"}
{"text": "BPH can exist without LUTS .The BPH sometimes causes blocks of bladder outflow [ 3 ] which cause pain and inflammation of the urinary tract .", "label": "", "metadata": {}, "score": "79.88754"}
{"text": "The study was conducted in accordance with ICH GCP , Indian GCP , and ICMR guideline with the provisions of the Declaration of Helsinki ( Seoul 2008 ) .", "label": "", "metadata": {}, "score": "80.34958"}
{"text": "Vitals were recorded at 2 , 4 , 6 , 8 , 12 , and 24 h after drug administration for each volunteer to assess health related complication if any .", "label": "", "metadata": {}, "score": "80.699005"}
{"text": "Do not give HYZAAR to other people , even if they have the same symptoms that you have .It may harm them .This leaflet summarizes the most important information about HYZAAR .", "label": "", "metadata": {}, "score": "80.88114"}
{"text": "Laboratory Test Findings .In controlled clinical trials , clinically important changes in standard laboratory parameters were rarely associated with administration of HYZAAR .Creatinine , Blood Urea Nitrogen : Minor increases in blood urea nitrogen ( BUN ) or serum creatinine were observed in 0.6 and 0.8 percent , respectively , of patients with essential hypertension treated with HYZAAR alone .", "label": "", "metadata": {}, "score": "81.064896"}
{"text": "Subject agrees to abstain from consuming alcohol for at least 48 hours prior to each dosing and throughout the periods when blood samples are being obtained .", "label": "", "metadata": {}, "score": "81.54124"}
{"text": "Hypo or hypertension of any etiologic that needs pharmacologic treatment .History or clinical case of myocardial infarction , angina and/or heart failure .The volunteer donated or lost 450 mL or more of blood within the 3 months prior to the study initiation .", "label": "", "metadata": {}, "score": "81.64851"}
{"text": "doi pubmed .Roth EM , Rosenson RS , Carlson DM , Fukumoto SM , Setze CM , Blasetto JW , Khurmi NS , et al .", "label": "", "metadata": {}, "score": "82.2882"}
{"text": "Hypokalemia may develop , especially with brisk diuresis , when severe cirrhosis is present , or after prolonged therapy .Interference with adequate oral electrolyte intake will also contribute to hypokalemia .", "label": "", "metadata": {}, "score": "83.01271"}
{"text": "\" Pharmaceutical Manufacturers ' Association , \" 115 154th Street , N.W. Washington , DC , USA , 2005 .J. P. Remington , Remington 'S Pharmaceutical ScienceS , Mack , Easton , Pa , USA , 15th edition , 1975 .", "label": "", "metadata": {}, "score": "83.583664"}
{"text": "Clin Ther . doi pubmed .Ginsberg HN , Elam MB , Lovato LC , Crouse JR , 3rd , Leiter LA , Linz P , Friedewald WT , et al .", "label": "", "metadata": {}, "score": "83.78386"}
{"text": "Inclusion Criteria : .Subjects should be at least 18 years old .Female subjects with negative serum pregnancy test .Subject with no clinically significant abnormal lab values at the pre - entry evaluation .", "label": "", "metadata": {}, "score": "83.82964"}
{"text": "The hydrochlorothiazide ingredient in HYZAAR works by making your kidneys pass more water and salt .Left Ventricular Hypertrophy ( LVH ) is an enlargement of the walls of the left chamber of the heart ( the heart 's main pumping chamber ) .", "label": "", "metadata": {}, "score": "84.13833"}
{"text": "The target hardness , thickness , friability , diameter , and machine speed were kept 4.5 kb , .rpm , respectively [ 28 ] .", "label": "", "metadata": {}, "score": "84.19942"}
{"text": "The primary endpoint was the first occurrence of cardiovascular death , nonfatal stroke , or nonfatal myocardial infarction .Race .In the LIFE study , Black patients treated with atenolol were at lower risk of experiencing the primary composite endpoint compared with Black patients treated with losartan .", "label": "", "metadata": {}, "score": "84.32564"}
{"text": "Conflict of Interest / Disclosure Information .HL has no conflicts of interest to disclose .JTL is an employee of AbbVie and may hold AbbVie stock or options .", "label": "", "metadata": {}, "score": "84.61578"}
{"text": "Dissolution media is 0.1 ( N ) hydrochloric acid ( a ) , acetate buffer ( b ) , and phosphate buffer ( c ) .", "label": "", "metadata": {}, "score": "85.068146"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "86.00155"}
{"text": "Blend analysis was conducted by sampling the mixture in the intermediate bulk containers [ 34 ] ( IBCs ) that is , stainless steel bunkers ( containers ) .", "label": "", "metadata": {}, "score": "86.41861"}
{"text": "Keywords : Bioavailability ; Fenofibrate ; Fenofibric acid ; Formulation ; Mixed dyslipidemia ; Triglycerides .Introduction .Cardiovascular disease ( CVD ) , in general , and coronary heart disease ( CHD ) , in particular , are leading causes of death in the United States [ 1 ] .", "label": "", "metadata": {}, "score": "86.48432"}
{"text": "Grundy SM , Cleeman JI , Merz CN , Brewer HB , Jr. , Clark LT , Hunninghake DB , Pasternak RC , et al .", "label": "", "metadata": {}, "score": "86.81932"}
{"text": "HYZAAR can harm your unborn baby causing injury and even death .Stop taking HYZAAR if you become pregnant and call your doctor right away .", "label": "", "metadata": {}, "score": "87.38658"}
{"text": "Subject has given a written consent to participate .Exclusion Criteria : .Subject has a history of chronic alcohol consumption ( during past 2 years ) or drug addiction .", "label": "", "metadata": {}, "score": "87.38665"}
{"text": "\u00a9The Author 2014 .Published by Oxford University Press .All rights reserved .[ Show abstract ] [ Hide abstract ] ABSTRACT : A simple , robust LC - MS / MS assay for quantifying cefuroxime in human plasma was developed .", "label": "", "metadata": {}, "score": "88.41049"}
{"text": "If you have liver problems , you may see a worsening in how well your liver works .Call your doctor if you get nausea , pain in the right upper stomach area ( abdomen ) , yellow eyes or skin ( which can be itchy ) .", "label": "", "metadata": {}, "score": "88.43524"}
{"text": "Oligohydramnios has also been reported , presumably resulting from decreased fetal renal function ; oligohydramnios in this setting has been associated with fetal limb contractures , craniofacial deformation , and hypoplastic lung development .", "label": "", "metadata": {}, "score": "89.542046"}
{"text": "4 , pp .1282 - 1289 , 1993 .View at Google Scholar \u00b7 View at Scopus .37 , no . 3 , pp .", "label": "", "metadata": {}, "score": "90.82254"}
{"text": "Circulation .2008;117(4):e25 - 146 . doi pubmed .Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) final report .", "label": "", "metadata": {}, "score": "91.45157"}
{"text": "Not Provided .Enrollment ICMJE .Completion Date .April 2003 .Primary Completion Date .March 2003 ( final data collection date for primary outcome measure ) .", "label": "", "metadata": {}, "score": "91.98486"}
{"text": "low blood pressure ( hypotension ) .Low blood pressure may cause you to feel faint or dizzy .Lie down if you feel faint or dizzy .", "label": "", "metadata": {}, "score": "92.16377"}
{"text": "A in vivo in vitro correlation ( IVIVC ) was tried to establish in order to select suitable in vitro dissolution media .To establish reasonable correlation , IVIVC link model was used which support linear regression only .", "label": "", "metadata": {}, "score": "93.25413"}
{"text": "a new or worsening condition called systemic lupus erythematosus ( Lupus ; SLE ) .if you have kidney problems , you may see a worsening in how well your kidneys work .", "label": "", "metadata": {}, "score": "93.777664"}
{"text": "All contents of the manuscript are written in English .The text adheres to the requirements outlined in the Author Guidelines .There must be a title page .", "label": "", "metadata": {}, "score": "93.901215"}
{"text": "The content of this site is intended for health care professionals .This is an open - access journal , published articles are distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "94.229706"}
{"text": "If you prepare your manuscript using a reference managing software , you should remove the field codes before submission .The authors have obtained written permission for the use of text , tables , and/or illustrations from any copyrighted sources .", "label": "", "metadata": {}, "score": "95.37941"}
{"text": "348 , no . 1 - 2 , pp .27 - 34 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "97.39813"}
{"text": "106 , no . 2 , pp .141 - 148 , 1994 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus", "label": "", "metadata": {}, "score": "97.57831"}
{"text": "183 , no . 2 , pp .155 - 164 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "100.707184"}
{"text": "\u00b0 C and paddle speed was 100 rpm at pH 1.2 and 4.5 whereas 50 rpm at pH 6.8 .Samples through a 40 \u03bc m filter were injected automatically at each sampling time point [ 32 ] .", "label": "", "metadata": {}, "score": "102.09825"}
{"text": "Lancet . doi .Fruchart JC , Sacks F , Hermans MP , Assmann G , Brown WV , Ceska R , Chapman MJ , et al .", "label": "", "metadata": {}, "score": "102.51714"}
{"text": "Lancet . doi .Kearney PM , Blackwell L , Collins R , Keech A , Simes J , Peto R , Armitage J , et al .", "label": "", "metadata": {}, "score": "106.56619"}
{"text": "High Blood Pressure ( hypertension ) Blood pressure is the force in your blood vessels when your heart beats and when your heart rests .You have high blood pressure when the force is too much .", "label": "", "metadata": {}, "score": "107.98202"}
{"text": "Received 1 September 2012 ; Accepted 3 October 2012 .Copyright \u00a9 2012 Utpal Kumar Sanki and Badal Kumar Mandal .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "109.150795"}
{"text": "doi pubmed .This is an open - access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "109.85608"}
{"text": "Copyright \u00a9 2012 Noppamas Rojanasthien et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "119.8519"}
